GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSRNOG00000014084 | Sp1 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp1 | rn6_v1_chr7_+_144014173_144014173 | -0.02 | 7.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_34186091 | 72.12 |
ENSRNOT00000016129
|
Sgtb
|
small glutamine rich tetratricopeptide repeat containing beta |
chr1_-_216663720 | 71.89 |
ENSRNOT00000078944
ENSRNOT00000077409 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C |
chr6_+_132246602 | 66.42 |
ENSRNOT00000009896
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr1_+_166564664 | 63.48 |
ENSRNOT00000090959
|
Pde2a
|
phosphodiesterase 2A |
chr5_+_156876706 | 59.36 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr7_+_123043503 | 59.34 |
ENSRNOT00000026258
ENSRNOT00000086355 |
Tef
|
TEF, PAR bZIP transcription factor |
chr3_+_152552822 | 57.35 |
ENSRNOT00000089719
|
Epb41l1
|
erythrocyte membrane protein band 4.1-like 1 |
chr1_+_80195532 | 57.31 |
ENSRNOT00000022528
|
Rtn2
|
reticulon 2 |
chr5_-_164971903 | 57.13 |
ENSRNOT00000067059
|
Fbxo44
|
F-box protein 44 |
chr16_-_20439206 | 56.45 |
ENSRNOT00000026391
|
Rab3a
|
RAB3A, member RAS oncogene family |
chr7_-_11353713 | 56.29 |
ENSRNOT00000061132
|
Zfr2
|
zinc finger RNA binding protein 2 |
chr3_+_80072489 | 55.37 |
ENSRNOT00000057176
|
Pacsin3
|
protein kinase C and casein kinase substrate in neurons 3 |
chr13_-_91872954 | 55.22 |
ENSRNOT00000004613
ENSRNOT00000079263 |
Cadm3
|
cell adhesion molecule 3 |
chr5_-_33182147 | 54.61 |
ENSRNOT00000080358
|
Maged2
|
MAGE family member D2 |
chr1_-_89483988 | 54.53 |
ENSRNOT00000028603
|
Fxyd7
|
FXYD domain-containing ion transport regulator 7 |
chr5_+_139783951 | 54.35 |
ENSRNOT00000081333
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr9_+_9961021 | 54.11 |
ENSRNOT00000075767
|
Tubb4a
|
tubulin, beta 4A class IVa |
chr3_+_58632476 | 53.47 |
ENSRNOT00000010630
|
Rapgef4
|
Rap guanine nucleotide exchange factor 4 |
chr7_-_70552897 | 51.41 |
ENSRNOT00000080594
|
Kif5a
|
kinesin family member 5A |
chr10_+_65586504 | 50.20 |
ENSRNOT00000015535
ENSRNOT00000046388 |
Aldoc
|
aldolase, fructose-bisphosphate C |
chr6_+_144384773 | 49.62 |
ENSRNOT00000006942
|
Ptprn2
|
protein tyrosine phosphatase, receptor type N2 |
chr7_-_132757558 | 49.03 |
ENSRNOT00000021153
|
Slc2a13
|
solute carrier family 2 member 13 |
chr13_-_86671515 | 48.72 |
ENSRNOT00000082869
|
AABR07021704.1
|
|
chr4_+_147037179 | 48.69 |
ENSRNOT00000011292
|
Syn2
|
synapsin II |
chr20_+_5050327 | 48.09 |
ENSRNOT00000083353
|
Ddah2
|
dimethylarginine dimethylaminohydrolase 2 |
chr10_-_82197848 | 47.13 |
ENSRNOT00000081307
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G |
chr1_+_198383201 | 46.62 |
ENSRNOT00000037405
|
Sez6l2
|
seizure related 6 homolog like 2 |
chr1_-_101351879 | 46.54 |
ENSRNOT00000028142
|
Ppfia3
|
PTPRF interacting protein alpha 3 |
chr9_-_82461903 | 46.28 |
ENSRNOT00000026654
|
Ptprn
|
protein tyrosine phosphatase, receptor type, N |
chr10_+_77755216 | 46.04 |
ENSRNOT00000087765
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr8_-_109621408 | 45.90 |
ENSRNOT00000087398
|
Ppp2r3a
|
protein phosphatase 2, regulatory subunit B'', alpha |
chr4_-_157679962 | 45.82 |
ENSRNOT00000050443
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase |
chrX_+_123205869 | 45.79 |
ENSRNOT00000017101
ENSRNOT00000079231 |
Pgrmc1
|
progesterone receptor membrane component 1 |
chr10_-_97896525 | 45.31 |
ENSRNOT00000005172
|
Wipi1
|
WD repeat domain, phosphoinositide interacting 1 |
chr14_+_83752393 | 45.18 |
ENSRNOT00000081123
|
Selenom
|
selenoprotein M |
chr3_-_163935617 | 44.77 |
ENSRNOT00000074023
|
Kcnb1
|
potassium voltage-gated channel subfamily B member 1 |
chr1_-_88908750 | 44.68 |
ENSRNOT00000028297
|
Aplp1
|
amyloid beta precursor like protein 1 |
chr10_+_86657285 | 44.66 |
ENSRNOT00000087346
|
Thra
|
thyroid hormone receptor alpha |
chr12_+_25173005 | 44.13 |
ENSRNOT00000033200
ENSRNOT00000091328 |
Clip2
|
CAP-GLY domain containing linker protein 2 |
chr10_-_91047177 | 43.85 |
ENSRNOT00000003986
|
C1ql1
|
complement C1q like 1 |
chr15_-_28314459 | 43.76 |
ENSRNOT00000042055
ENSRNOT00000040540 |
Ndrg2
|
NDRG family member 2 |
chr3_-_105279462 | 43.55 |
ENSRNOT00000010679
|
Scg5
|
secretogranin V |
chr10_-_56444847 | 42.81 |
ENSRNOT00000056872
ENSRNOT00000092662 |
Nlgn2
|
neuroligin 2 |
chr7_-_115988036 | 42.68 |
ENSRNOT00000076822
|
Lynx1
|
Ly6/neurotoxin 1 |
chr3_+_41019898 | 42.62 |
ENSRNOT00000007335
|
Kcnj3
|
potassium voltage-gated channel subfamily J member 3 |
chr7_-_145154131 | 42.37 |
ENSRNOT00000055271
|
Ppp1r1a
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr7_-_130128589 | 42.35 |
ENSRNOT00000079777
ENSRNOT00000009325 |
Mapk11
|
mitogen-activated protein kinase 11 |
chr10_-_103919605 | 42.06 |
ENSRNOT00000004718
|
Hid1
|
HID1 domain containing |
chr13_+_70379346 | 41.92 |
ENSRNOT00000038183
|
Nmnat2
|
nicotinamide nucleotide adenylyltransferase 2 |
chrX_+_157095937 | 41.74 |
ENSRNOT00000091792
|
Bcap31
|
B-cell receptor-associated protein 31 |
chr13_-_52197205 | 41.50 |
ENSRNOT00000009712
|
Shisa4
|
shisa family member 4 |
chr3_+_113251778 | 41.49 |
ENSRNOT00000083005
|
Map1a
|
microtubule-associated protein 1A |
chr8_-_132345708 | 41.08 |
ENSRNOT00000006300
|
Tmem158
|
transmembrane protein 158 |
chr14_-_36554580 | 41.01 |
ENSRNOT00000002869
|
Rasl11b
|
RAS-like family 11 member B |
chr5_+_28395296 | 40.95 |
ENSRNOT00000009375
|
Tmem55a
|
transmembrane protein 55A |
chr8_+_44136496 | 40.93 |
ENSRNOT00000087022
|
Scn3b
|
sodium voltage-gated channel beta subunit 3 |
chr5_-_144779212 | 40.91 |
ENSRNOT00000016230
|
Ncdn
|
neurochondrin |
chr1_+_234252757 | 40.75 |
ENSRNOT00000091814
|
Rorb
|
RAR-related orphan receptor B |
chr8_+_55178289 | 40.51 |
ENSRNOT00000059127
|
Cryab
|
crystallin, alpha B |
chr4_-_169999873 | 40.48 |
ENSRNOT00000011697
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B |
chr1_-_64099277 | 40.41 |
ENSRNOT00000084846
|
Tsen34
|
tRNA splicing endonuclease subunit 34 |
chr10_-_39405311 | 40.41 |
ENSRNOT00000074616
|
Pdlim4
|
PDZ and LIM domain 4 |
chr4_-_16130848 | 40.14 |
ENSRNOT00000042914
|
Cacna2d1
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
chr19_+_37476095 | 39.91 |
ENSRNOT00000092794
ENSRNOT00000023130 |
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr1_-_146556171 | 39.91 |
ENSRNOT00000017636
|
Arnt2
|
aryl hydrocarbon receptor nuclear translocator 2 |
chr2_+_27107318 | 39.88 |
ENSRNOT00000019553
|
Arhgef26
|
Rho guanine nucleotide exchange factor 26 |
chr2_-_188138177 | 39.69 |
ENSRNOT00000027474
|
Syt11
|
synaptotagmin 11 |
chr14_-_85191557 | 39.68 |
ENSRNOT00000011604
|
Nefh
|
neurofilament heavy |
chr11_-_31752243 | 39.23 |
ENSRNOT00000002775
|
Tmem50b
|
transmembrane protein 50B |
chr1_-_211265161 | 38.95 |
ENSRNOT00000080041
ENSRNOT00000023477 |
Bnip3
|
BCL2 interacting protein 3 |
chrX_+_107370431 | 38.95 |
ENSRNOT00000044372
|
Tceal1
|
transcription elongation factor A like 1 |
chrX_+_39711201 | 38.93 |
ENSRNOT00000080512
ENSRNOT00000009802 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr1_+_101161252 | 38.88 |
ENSRNOT00000028064
ENSRNOT00000064184 |
Slc17a7
|
solute carrier family 17 member 7 |
chr6_-_28464118 | 38.55 |
ENSRNOT00000068214
|
Efr3b
|
EFR3 homolog B |
chr4_+_89078711 | 38.30 |
ENSRNOT00000010241
|
Herc3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
chr14_+_78640620 | 38.00 |
ENSRNOT00000034730
|
Wfs1
|
wolframin ER transmembrane glycoprotein |
chr1_+_162768156 | 37.96 |
ENSRNOT00000049321
|
Pak1
|
p21 (RAC1) activated kinase 1 |
chr5_+_155812105 | 37.94 |
ENSRNOT00000039341
|
AABR07073181.1
|
|
chr5_+_128501847 | 37.83 |
ENSRNOT00000010645
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr4_-_16130563 | 37.78 |
ENSRNOT00000090240
ENSRNOT00000034969 |
Cacna2d1
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
chr10_-_46720907 | 37.52 |
ENSRNOT00000083093
ENSRNOT00000067866 |
Tom1l2
|
target of myb1 like 2 membrane trafficking protein |
chr2_+_121165137 | 37.40 |
ENSRNOT00000016236
|
Sox2
|
SRY box 2 |
chr2_+_174013288 | 37.12 |
ENSRNOT00000013904
|
Serpini1
|
serpin family I member 1 |
chr14_+_60123169 | 36.87 |
ENSRNOT00000006610
|
Sel1l3
|
SEL1L family member 3 |
chr2_+_207923775 | 36.66 |
ENSRNOT00000019997
ENSRNOT00000051835 |
Kcnd3
|
potassium voltage-gated channel subfamily D member 3 |
chr9_+_96210750 | 36.64 |
ENSRNOT00000026312
|
Sh3bp4
|
SH3-domain binding protein 4 |
chr9_+_82674202 | 36.54 |
ENSRNOT00000027208
|
Tmem198
|
transmembrane protein 198 |
chr7_+_12433933 | 36.34 |
ENSRNOT00000060690
|
Cbarp
|
CACN beta subunit associated regulatory protein |
chr20_+_5049496 | 36.20 |
ENSRNOT00000088251
ENSRNOT00000001118 |
Ddah2
|
dimethylarginine dimethylaminohydrolase 2 |
chrX_-_6620722 | 36.19 |
ENSRNOT00000066674
|
Maoa
|
monoamine oxidase A |
chr3_+_113319456 | 36.05 |
ENSRNOT00000051354
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr6_+_10306405 | 35.97 |
ENSRNOT00000090420
ENSRNOT00000080507 |
Epas1
|
endothelial PAS domain protein 1 |
chr1_-_212548730 | 35.78 |
ENSRNOT00000089729
|
Caly
|
calcyon neuron-specific vesicular protein |
chrX_-_157139291 | 35.69 |
ENSRNOT00000092123
|
Slc6a8
|
solute carrier family 6 member 8 |
chrX_-_54303729 | 35.54 |
ENSRNOT00000087919
ENSRNOT00000064340 ENSRNOT00000051249 ENSRNOT00000087547 |
Gk
|
glycerol kinase |
chr5_-_58019836 | 35.45 |
ENSRNOT00000066977
|
Enho
|
energy homeostasis associated |
chr1_-_170464341 | 35.36 |
ENSRNOT00000024850
|
Trim3
|
tripartite motif-containing 3 |
chr8_-_49045154 | 35.29 |
ENSRNOT00000088034
|
Phldb1
|
pleckstrin homology-like domain, family B, member 1 |
chr10_-_65766050 | 35.19 |
ENSRNOT00000013639
|
Sarm1
|
sterile alpha and TIR motif containing 1 |
chr9_+_17340341 | 35.06 |
ENSRNOT00000026637
ENSRNOT00000026559 ENSRNOT00000042790 ENSRNOT00000044163 ENSRNOT00000083811 |
Vegfa
|
vascular endothelial growth factor A |
chr19_-_9777465 | 34.97 |
ENSRNOT00000017413
|
Ndrg4
|
NDRG family member 4 |
chr10_+_56445647 | 34.69 |
ENSRNOT00000056870
|
Tmem256
|
transmembrane protein 256 |
chr9_-_100253609 | 34.66 |
ENSRNOT00000036061
|
Kif1a
|
kinesin family member 1A |
chr17_-_10364503 | 34.60 |
ENSRNOT00000086380
ENSRNOT00000041709 |
Tspan17
|
tetraspanin 17 |
chr2_-_148050423 | 34.44 |
ENSRNOT00000064506
ENSRNOT00000023469 |
LOC100909840
|
profilin-2-like |
chr13_-_70783515 | 34.32 |
ENSRNOT00000003605
|
Lamc1
|
laminin subunit gamma 1 |
chr8_+_118333706 | 34.32 |
ENSRNOT00000028278
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr4_-_52350624 | 34.24 |
ENSRNOT00000060476
|
Tmem229a
|
transmembrane protein 229A |
chr2_+_218951451 | 34.22 |
ENSRNOT00000019190
|
Extl2
|
exostosin-like glycosyltransferase 2 |
chrX_+_20484517 | 33.96 |
ENSRNOT00000093701
|
FAM120C
|
family with sequence similarity 120C |
chr3_+_161425988 | 33.86 |
ENSRNOT00000065184
|
Slc12a5
|
solute carrier family 12 member 5 |
chr13_+_41883137 | 33.81 |
ENSRNOT00000004581
|
Slc35f5
|
solute carrier family 35, member F5 |
chr1_-_198454914 | 33.74 |
ENSRNOT00000049044
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr1_+_266530477 | 33.67 |
ENSRNOT00000054699
|
Cnnm2
|
cyclin and CBS domain divalent metal cation transport mediator 2 |
chr1_-_71290337 | 33.59 |
ENSRNOT00000063956
|
Zfp667
|
zinc finger protein 667 |
chr3_+_92969141 | 33.57 |
ENSRNOT00000009797
|
Apip
|
APAF1 interacting protein |
chr15_+_104095179 | 33.24 |
ENSRNOT00000093487
|
Cldn10
|
claudin 10 |
chr5_-_114014277 | 33.14 |
ENSRNOT00000011731
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit |
chr9_+_99998275 | 33.07 |
ENSRNOT00000074395
|
Gpc1
|
glypican 1 |
chr5_-_85123829 | 32.96 |
ENSRNOT00000007578
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1 |
chr12_+_39553903 | 32.90 |
ENSRNOT00000001738
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
chr8_-_94564525 | 32.84 |
ENSRNOT00000084437
|
Snap91
|
synaptosomal-associated protein 91 |
chr10_-_82887497 | 32.77 |
ENSRNOT00000005644
|
Itga3
|
integrin subunit alpha 3 |
chr1_+_101687855 | 32.63 |
ENSRNOT00000028546
ENSRNOT00000091597 |
Dbp
|
D-box binding PAR bZIP transcription factor |
chr2_-_250600517 | 32.58 |
ENSRNOT00000016872
|
Hs2st1
|
heparan sulfate 2-O-sulfotransferase 1 |
chr8_-_58293102 | 32.39 |
ENSRNOT00000011913
|
Rab39a
|
RAB39A, member RAS oncogene family |
chr2_+_22909569 | 32.20 |
ENSRNOT00000073871
|
Homer1
|
homer scaffolding protein 1 |
chrX_+_19243759 | 32.14 |
ENSRNOT00000004238
|
Mageh1
|
MAGE family member H1 |
chr19_-_9801942 | 32.11 |
ENSRNOT00000051414
ENSRNOT00000017494 |
Ndrg4
|
NDRG family member 4 |
chr9_-_83253458 | 32.07 |
ENSRNOT00000041689
|
Epha4
|
Eph receptor A4 |
chr10_+_74871523 | 32.01 |
ENSRNOT00000076995
ENSRNOT00000076026 ENSRNOT00000088581 ENSRNOT00000076701 |
Sept4
|
septin 4 |
chr18_+_83471342 | 31.88 |
ENSRNOT00000019384
|
Neto1
|
neuropilin and tolloid like 1 |
chr1_+_100393303 | 31.81 |
ENSRNOT00000026251
|
Syt3
|
synaptotagmin 3 |
chr10_+_56627411 | 31.69 |
ENSRNOT00000089108
ENSRNOT00000068493 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr2_-_172459165 | 31.55 |
ENSRNOT00000057473
|
Schip1
|
schwannomin interacting protein 1 |
chr3_-_11382004 | 31.52 |
ENSRNOT00000047921
ENSRNOT00000064039 |
Dnm1
|
dynamin 1 |
chr18_-_57245666 | 31.49 |
ENSRNOT00000080365
|
Ablim3
|
actin binding LIM protein family, member 3 |
chr10_+_59585072 | 31.37 |
ENSRNOT00000025009
|
Camkk1
|
calcium/calmodulin-dependent protein kinase kinase 1 |
chr3_+_6773813 | 31.30 |
ENSRNOT00000065953
ENSRNOT00000013443 |
Olfm1
|
olfactomedin 1 |
chr2_+_85377318 | 31.05 |
ENSRNOT00000016506
ENSRNOT00000085094 |
Sema5a
|
semaphorin 5A |
chr7_-_116607674 | 31.02 |
ENSRNOT00000076014
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr5_+_138154673 | 31.01 |
ENSRNOT00000064452
|
Slc2a1
|
solute carrier family 2 member 1 |
chrX_+_37329779 | 31.01 |
ENSRNOT00000038352
ENSRNOT00000088802 |
Pdha1
|
pyruvate dehydrogenase (lipoamide) alpha 1 |
chr6_+_64297888 | 30.86 |
ENSRNOT00000050222
ENSRNOT00000083088 ENSRNOT00000093147 |
Nrcam
|
neuronal cell adhesion molecule |
chr14_+_114126943 | 30.68 |
ENSRNOT00000041638
ENSRNOT00000006443 ENSRNOT00000006957 |
Rtn4
|
reticulon 4 |
chr3_-_153893847 | 30.47 |
ENSRNOT00000085938
|
LOC100911769
|
band 4.1-like protein 1-like |
chr12_+_39554171 | 30.44 |
ENSRNOT00000024347
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
chr7_-_118396728 | 30.42 |
ENSRNOT00000066431
|
Rbfox2
|
RNA binding protein, fox-1 homolog 2 |
chr5_-_151709877 | 30.38 |
ENSRNOT00000080602
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr2_+_225005019 | 30.29 |
ENSRNOT00000015579
|
Cnn3
|
calponin 3 |
chr10_-_104358253 | 30.28 |
ENSRNOT00000005942
|
Caskin2
|
cask-interacting protein 2 |
chr1_+_84067938 | 29.84 |
ENSRNOT00000057213
|
Numbl
|
NUMB-like, endocytic adaptor protein |
chr6_+_42180894 | 29.72 |
ENSRNOT00000006403
ENSRNOT00000090816 |
Rock2
|
Rho-associated coiled-coil containing protein kinase 2 |
chr1_-_100671074 | 29.72 |
ENSRNOT00000027132
|
Myh14
|
myosin heavy chain 14 |
chr2_-_166682325 | 29.63 |
ENSRNOT00000091198
ENSRNOT00000012422 |
Sptssb
|
serine palmitoyltransferase, small subunit B |
chr7_+_54980120 | 29.58 |
ENSRNOT00000005690
ENSRNOT00000005773 |
Kcnc2
|
potassium voltage-gated channel subfamily C member 2 |
chr1_-_72727112 | 29.57 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr16_+_20521956 | 29.38 |
ENSRNOT00000026597
|
Pgpep1
|
pyroglutamyl-peptidase I |
chr11_-_68842320 | 29.36 |
ENSRNOT00000049180
|
Adcy5
|
adenylate cyclase 5 |
chr15_+_15275541 | 29.34 |
ENSRNOT00000012153
|
Cadps
|
calcium dependent secretion activator |
chr2_-_29768750 | 29.29 |
ENSRNOT00000023460
|
Map1b
|
microtubule-associated protein 1B |
chrX_+_63520991 | 29.25 |
ENSRNOT00000071590
|
Apoo
|
apolipoprotein O |
chr6_+_43001948 | 29.16 |
ENSRNOT00000007374
|
Hpcal1
|
hippocalcin-like 1 |
chr18_-_16497886 | 29.11 |
ENSRNOT00000021624
|
Rprd1a
|
regulation of nuclear pre-mRNA domain containing 1A |
chr1_+_39811314 | 29.10 |
ENSRNOT00000022046
|
Ppp1r14c
|
protein phosphatase 1, regulatory (inhibitor) subunit 14c |
chr14_+_36687134 | 29.00 |
ENSRNOT00000002879
|
Usp46
|
ubiquitin specific peptidase 46 |
chr7_-_105592804 | 28.94 |
ENSRNOT00000006789
|
Adcy8
|
adenylate cyclase 8 |
chr5_+_43603043 | 28.78 |
ENSRNOT00000009899
|
Epha7
|
Eph receptor A7 |
chr2_+_226900619 | 28.72 |
ENSRNOT00000019638
|
Pde5a
|
phosphodiesterase 5A |
chr20_+_5535432 | 28.72 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr3_-_149905944 | 28.63 |
ENSRNOT00000021715
|
Snta1
|
syntrophin, alpha 1 |
chr8_+_44847157 | 28.60 |
ENSRNOT00000080288
|
Clmp
|
CXADR-like membrane protein |
chr5_-_166259069 | 28.58 |
ENSRNOT00000055572
|
Ube4b
|
ubiquitination factor E4B |
chr13_-_111765944 | 28.55 |
ENSRNOT00000073041
|
Syt14
|
synaptotagmin 14 |
chrX_-_15707436 | 28.54 |
ENSRNOT00000085907
|
Syp
|
synaptophysin |
chr1_+_36320461 | 28.53 |
ENSRNOT00000023659
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr12_+_37490584 | 28.47 |
ENSRNOT00000001401
ENSRNOT00000090831 |
Rilpl1
|
Rab interacting lysosomal protein-like 1 |
chr10_-_85684138 | 28.43 |
ENSRNOT00000017989
|
Pip4k2b
|
phosphatidylinositol-5-phosphate 4-kinase type 2 beta |
chr8_-_22821223 | 28.30 |
ENSRNOT00000014135
|
Kank2
|
KN motif and ankyrin repeat domains 2 |
chr6_+_43829945 | 28.30 |
ENSRNOT00000086548
|
Klf11
|
Kruppel-like factor 11 |
chr12_-_22211071 | 28.27 |
ENSRNOT00000087817
ENSRNOT00000001910 |
Actl6b
|
actin-like 6B |
chr12_+_23789638 | 28.22 |
ENSRNOT00000001954
ENSRNOT00000084730 |
Ywhag
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
chrX_+_69730242 | 28.18 |
ENSRNOT00000075980
ENSRNOT00000076425 |
Eda
|
ectodysplasin-A |
chr4_+_44573264 | 28.17 |
ENSRNOT00000080271
|
Cav2
|
caveolin 2 |
chr7_-_116607408 | 28.16 |
ENSRNOT00000076009
ENSRNOT00000056554 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chrX_-_134719097 | 28.14 |
ENSRNOT00000068478
|
Smarca1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr12_+_15890170 | 28.11 |
ENSRNOT00000001654
|
Gna12
|
G protein subunit alpha 12 |
chr7_+_123381077 | 28.01 |
ENSRNOT00000082603
ENSRNOT00000056041 |
Srebf2
|
sterol regulatory element binding transcription factor 2 |
chr10_-_103826448 | 27.92 |
ENSRNOT00000085636
|
Fdxr
|
ferredoxin reductase |
chr19_+_20607507 | 27.90 |
ENSRNOT00000000011
|
Cbln1
|
cerebellin 1 precursor |
chr1_+_221792221 | 27.88 |
ENSRNOT00000054828
|
Nrxn2
|
neurexin 2 |
chr6_+_76675418 | 27.82 |
ENSRNOT00000076169
ENSRNOT00000010948 ENSRNOT00000082286 |
Brms1l
Brms1l
|
breast cancer metastasis-suppressor 1-like breast cancer metastasis-suppressor 1-like |
chrX_+_105573909 | 27.80 |
ENSRNOT00000029664
|
Armcx3
|
armadillo repeat containing, X-linked 3 |
chr1_-_64030175 | 27.72 |
ENSRNOT00000089950
|
Tsen34l1
|
tRNA splicing endonuclease subunit 34-like 1 |
chr15_-_44860604 | 27.69 |
ENSRNOT00000018637
|
Nefm
|
neurofilament medium |
chr8_+_128972311 | 27.51 |
ENSRNOT00000025460
|
Myrip
|
myosin VIIA and Rab interacting protein |
chr5_+_166464252 | 27.48 |
ENSRNOT00000055562
|
Ctnnbip1
|
catenin, beta-interacting protein 1 |
chr6_-_135829953 | 27.45 |
ENSRNOT00000080623
ENSRNOT00000039059 |
Cdc42bpb
|
CDC42 binding protein kinase beta |
chr3_+_2625015 | 27.35 |
ENSRNOT00000018927
|
Npdc1
|
neural proliferation, differentiation and control, 1 |
chr3_-_107760550 | 27.28 |
ENSRNOT00000077091
ENSRNOT00000051638 |
Meis2
|
Meis homeobox 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.0 | 75.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
22.8 | 68.5 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
22.5 | 67.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
20.2 | 80.8 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
19.1 | 57.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
18.9 | 37.9 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
18.9 | 56.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
17.4 | 52.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
17.2 | 68.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
16.7 | 50.0 | GO:0001966 | thigmotaxis(GO:0001966) |
16.6 | 66.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
16.5 | 82.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
15.6 | 62.5 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
15.5 | 46.5 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
15.5 | 62.0 | GO:0007525 | somatic muscle development(GO:0007525) |
15.1 | 60.5 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
14.8 | 29.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
14.5 | 14.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
14.5 | 43.4 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
14.5 | 86.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
14.3 | 42.9 | GO:0035607 | ventricular zone neuroblast division(GO:0021847) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
14.1 | 42.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
14.0 | 41.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
13.9 | 41.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
13.8 | 96.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
13.8 | 13.8 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
13.7 | 41.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
13.4 | 67.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
13.3 | 40.0 | GO:0006574 | valine catabolic process(GO:0006574) |
13.3 | 39.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
13.1 | 13.1 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
13.0 | 130.4 | GO:0036376 | sodium ion export from cell(GO:0036376) |
13.0 | 39.1 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
13.0 | 117.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
13.0 | 65.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
13.0 | 77.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
12.7 | 38.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
12.6 | 37.8 | GO:0046038 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
12.4 | 62.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
12.4 | 74.1 | GO:0010045 | response to nickel cation(GO:0010045) |
12.3 | 12.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
12.1 | 24.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
12.0 | 36.0 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
11.9 | 35.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
11.8 | 35.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
11.7 | 35.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
11.7 | 35.2 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
11.6 | 34.9 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
11.5 | 23.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
11.4 | 11.4 | GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
11.4 | 11.4 | GO:1900673 | olefin metabolic process(GO:1900673) |
11.3 | 33.9 | GO:0060082 | eye blink reflex(GO:0060082) |
11.3 | 45.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
11.3 | 45.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
11.3 | 67.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
10.9 | 32.6 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
10.7 | 64.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
10.7 | 53.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
10.6 | 31.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
10.5 | 10.5 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
10.5 | 21.0 | GO:0035711 | T-helper 1 cell activation(GO:0035711) |
10.5 | 31.4 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
10.4 | 31.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
10.2 | 40.9 | GO:0072218 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
10.2 | 71.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
10.2 | 40.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
10.0 | 30.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
9.9 | 29.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
9.8 | 9.8 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
9.8 | 9.8 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
9.8 | 126.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
9.6 | 28.8 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
9.6 | 86.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
9.6 | 57.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
9.6 | 19.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
9.5 | 28.6 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
9.5 | 28.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
9.5 | 38.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
9.5 | 28.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
9.4 | 37.7 | GO:0021590 | cerebellum maturation(GO:0021590) |
9.4 | 28.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
9.4 | 37.5 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
9.4 | 28.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
9.3 | 37.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
9.3 | 9.3 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
9.2 | 64.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
9.2 | 9.2 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
9.2 | 46.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
9.2 | 45.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
9.1 | 45.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
9.1 | 54.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
9.1 | 27.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
9.0 | 9.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
9.0 | 71.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
8.9 | 17.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
8.8 | 17.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
8.8 | 43.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
8.6 | 25.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
8.6 | 17.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
8.5 | 25.6 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
8.5 | 8.5 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
8.4 | 25.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
8.4 | 8.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
8.4 | 58.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
8.4 | 25.1 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
8.3 | 107.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
8.3 | 24.8 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
8.3 | 49.5 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
8.3 | 33.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
8.2 | 49.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
8.2 | 24.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
8.2 | 24.6 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
8.2 | 65.7 | GO:0015866 | ADP transport(GO:0015866) |
8.2 | 16.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
8.1 | 16.3 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
8.1 | 40.7 | GO:0019563 | glycerol catabolic process(GO:0019563) |
8.1 | 32.5 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
8.1 | 64.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
8.1 | 40.5 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
8.1 | 64.7 | GO:0035934 | corticosterone secretion(GO:0035934) |
8.0 | 40.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
8.0 | 24.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
8.0 | 40.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
8.0 | 24.1 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
8.0 | 40.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
8.0 | 15.9 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
7.9 | 7.9 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
7.9 | 23.6 | GO:0045751 | regulation of Toll signaling pathway(GO:0008592) negative regulation of Toll signaling pathway(GO:0045751) |
7.8 | 70.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
7.8 | 54.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
7.8 | 15.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
7.8 | 15.5 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
7.7 | 92.6 | GO:0007614 | short-term memory(GO:0007614) |
7.7 | 7.7 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
7.6 | 38.0 | GO:0061743 | motor learning(GO:0061743) |
7.6 | 22.8 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
7.6 | 22.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
7.6 | 53.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
7.6 | 37.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
7.5 | 45.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
7.5 | 22.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
7.5 | 22.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
7.4 | 22.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
7.4 | 14.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
7.3 | 29.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
7.3 | 36.5 | GO:0002159 | desmosome assembly(GO:0002159) |
7.3 | 7.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
7.3 | 7.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
7.3 | 58.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
7.2 | 21.7 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
7.2 | 21.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
7.2 | 43.1 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
7.2 | 43.0 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
7.1 | 14.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
7.1 | 28.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
7.1 | 21.3 | GO:0071529 | cementum mineralization(GO:0071529) |
7.1 | 42.5 | GO:0046959 | habituation(GO:0046959) |
7.1 | 70.7 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
7.1 | 35.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
7.0 | 7.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
7.0 | 21.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
7.0 | 42.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
7.0 | 7.0 | GO:1901219 | regulation of cardiac chamber morphogenesis(GO:1901219) negative regulation of cardiac chamber morphogenesis(GO:1901220) |
6.9 | 13.9 | GO:0046958 | nonassociative learning(GO:0046958) |
6.9 | 55.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
6.9 | 34.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
6.9 | 6.9 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
6.9 | 27.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
6.9 | 20.8 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
6.9 | 90.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
6.9 | 76.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
6.9 | 55.3 | GO:0015871 | choline transport(GO:0015871) |
6.9 | 34.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
6.8 | 13.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
6.8 | 20.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
6.8 | 20.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
6.7 | 27.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
6.7 | 20.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
6.7 | 80.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
6.7 | 40.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
6.7 | 13.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
6.7 | 46.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
6.6 | 26.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
6.6 | 6.6 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
6.6 | 92.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
6.6 | 19.9 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
6.6 | 26.3 | GO:0021586 | pons maturation(GO:0021586) |
6.6 | 19.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
6.6 | 26.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
6.5 | 45.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
6.5 | 19.6 | GO:0019541 | acetate metabolic process(GO:0006083) propionate metabolic process(GO:0019541) |
6.5 | 19.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
6.5 | 32.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
6.5 | 19.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
6.5 | 25.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
6.5 | 25.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
6.4 | 32.2 | GO:0044691 | tooth eruption(GO:0044691) |
6.4 | 19.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
6.4 | 6.4 | GO:0070370 | cellular heat acclimation(GO:0070370) |
6.4 | 6.4 | GO:0072554 | blood vessel lumenization(GO:0072554) |
6.4 | 25.5 | GO:0060594 | mammary gland specification(GO:0060594) |
6.4 | 19.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
6.4 | 25.4 | GO:0032264 | IMP salvage(GO:0032264) |
6.3 | 6.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
6.3 | 19.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
6.3 | 19.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
6.3 | 44.2 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
6.3 | 12.6 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
6.2 | 18.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
6.2 | 18.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
6.2 | 24.9 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
6.2 | 18.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
6.2 | 92.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
6.2 | 24.8 | GO:0060023 | soft palate development(GO:0060023) |
6.1 | 24.6 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
6.1 | 6.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
6.1 | 18.2 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
6.1 | 85.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
6.0 | 24.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
6.0 | 42.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
6.0 | 12.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
6.0 | 18.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
6.0 | 12.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
6.0 | 11.9 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
6.0 | 17.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
6.0 | 11.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
5.9 | 29.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
5.9 | 23.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
5.9 | 17.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
5.9 | 23.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
5.9 | 17.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
5.9 | 35.2 | GO:0021759 | globus pallidus development(GO:0021759) |
5.9 | 35.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
5.9 | 5.9 | GO:1904056 | regulation of cholangiocyte proliferation(GO:1904054) positive regulation of cholangiocyte proliferation(GO:1904056) |
5.9 | 11.7 | GO:0006116 | NADH oxidation(GO:0006116) |
5.8 | 17.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
5.8 | 63.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
5.8 | 11.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
5.8 | 34.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
5.8 | 5.8 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
5.8 | 17.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
5.8 | 17.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
5.7 | 68.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
5.7 | 45.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
5.7 | 11.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
5.7 | 22.8 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
5.7 | 5.7 | GO:1902837 | amino acid import into cell(GO:1902837) |
5.7 | 17.0 | GO:0006214 | thymidine catabolic process(GO:0006214) pyrimidine deoxyribonucleoside catabolic process(GO:0046127) |
5.7 | 22.6 | GO:0060022 | hard palate development(GO:0060022) |
5.7 | 5.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
5.6 | 33.7 | GO:0035900 | response to isolation stress(GO:0035900) |
5.6 | 11.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
5.5 | 5.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
5.5 | 5.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
5.5 | 16.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
5.5 | 5.5 | GO:0009644 | response to high light intensity(GO:0009644) |
5.4 | 5.4 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
5.4 | 32.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
5.4 | 16.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
5.4 | 43.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
5.4 | 16.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
5.4 | 16.2 | GO:0090504 | wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
5.4 | 10.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
5.4 | 21.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
5.4 | 21.5 | GO:0015746 | citrate transport(GO:0015746) |
5.4 | 10.8 | GO:1900126 | regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
5.4 | 21.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
5.4 | 16.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
5.4 | 21.4 | GO:0036394 | amylase secretion(GO:0036394) |
5.4 | 5.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
5.4 | 5.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
5.3 | 21.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
5.3 | 74.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
5.3 | 15.9 | GO:0035989 | tendon development(GO:0035989) |
5.3 | 126.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
5.3 | 21.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
5.3 | 5.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
5.3 | 15.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
5.2 | 5.2 | GO:0061526 | acetylcholine secretion(GO:0061526) |
5.2 | 52.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
5.2 | 5.2 | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
5.2 | 10.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
5.2 | 26.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
5.2 | 36.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
5.1 | 15.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
5.1 | 30.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
5.1 | 20.6 | GO:0046083 | adenine metabolic process(GO:0046083) |
5.1 | 15.4 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
5.1 | 20.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
5.1 | 15.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
5.1 | 20.4 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
5.1 | 5.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
5.1 | 20.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
5.1 | 15.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
5.1 | 15.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
5.0 | 65.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
5.0 | 15.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
5.0 | 50.3 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
5.0 | 181.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
5.0 | 55.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
5.0 | 70.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
5.0 | 205.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
5.0 | 40.0 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
5.0 | 44.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
5.0 | 24.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
5.0 | 29.8 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
5.0 | 29.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
4.9 | 14.8 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
4.9 | 14.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
4.9 | 4.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
4.9 | 133.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
4.9 | 93.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.9 | 24.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
4.9 | 24.6 | GO:0051182 | coenzyme transport(GO:0051182) |
4.9 | 9.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
4.9 | 63.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
4.9 | 39.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
4.9 | 4.9 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
4.9 | 68.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
4.9 | 14.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
4.9 | 19.4 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
4.8 | 33.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
4.8 | 19.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
4.8 | 19.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
4.8 | 4.8 | GO:1904313 | response to methamphetamine hydrochloride(GO:1904313) |
4.8 | 4.8 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
4.8 | 28.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
4.8 | 62.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
4.8 | 9.6 | GO:2001055 | activation of meiosis(GO:0090427) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
4.8 | 19.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
4.8 | 14.4 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
4.8 | 4.8 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
4.8 | 4.8 | GO:0034760 | negative regulation of iron ion transmembrane transport(GO:0034760) |
4.8 | 19.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
4.8 | 9.6 | GO:0097037 | heme export(GO:0097037) |
4.8 | 28.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
4.8 | 14.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
4.8 | 42.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
4.8 | 38.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
4.7 | 9.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
4.7 | 33.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
4.7 | 14.1 | GO:0042756 | drinking behavior(GO:0042756) |
4.7 | 89.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
4.7 | 32.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
4.7 | 9.4 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
4.7 | 14.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
4.7 | 14.0 | GO:0003383 | apical constriction(GO:0003383) |
4.7 | 51.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
4.6 | 18.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
4.6 | 13.9 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
4.6 | 23.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
4.6 | 73.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
4.6 | 23.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
4.6 | 4.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
4.6 | 55.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
4.6 | 9.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
4.6 | 13.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
4.6 | 22.8 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
4.5 | 22.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
4.5 | 9.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
4.5 | 9.0 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
4.5 | 9.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
4.5 | 13.5 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
4.5 | 27.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.5 | 9.0 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
4.5 | 4.5 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
4.5 | 8.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
4.5 | 133.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
4.5 | 17.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
4.4 | 26.7 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
4.4 | 13.3 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
4.4 | 30.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
4.4 | 8.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
4.4 | 13.2 | GO:0097187 | dentinogenesis(GO:0097187) |
4.4 | 13.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
4.4 | 39.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
4.4 | 39.2 | GO:0060013 | righting reflex(GO:0060013) |
4.3 | 17.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
4.3 | 25.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
4.3 | 4.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
4.3 | 4.3 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
4.3 | 17.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
4.3 | 34.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
4.3 | 55.6 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
4.3 | 12.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
4.3 | 4.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
4.2 | 8.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
4.2 | 17.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
4.2 | 16.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
4.2 | 12.7 | GO:0016487 | sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
4.2 | 29.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.2 | 8.4 | GO:1905077 | regulation of interleukin-17 secretion(GO:1905076) negative regulation of interleukin-17 secretion(GO:1905077) |
4.2 | 25.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
4.2 | 12.5 | GO:0010625 | positive regulation of Schwann cell proliferation(GO:0010625) |
4.2 | 4.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
4.2 | 12.5 | GO:0072720 | response to dithiothreitol(GO:0072720) |
4.2 | 16.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
4.1 | 29.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
4.1 | 70.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
4.1 | 12.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
4.1 | 20.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
4.1 | 20.7 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
4.1 | 12.4 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
4.1 | 33.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
4.1 | 12.4 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
4.1 | 12.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
4.1 | 8.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
4.1 | 4.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
4.1 | 77.7 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
4.1 | 44.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
4.1 | 12.3 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
4.1 | 85.7 | GO:0001553 | luteinization(GO:0001553) |
4.1 | 28.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
4.1 | 8.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
4.1 | 12.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
4.0 | 16.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
4.0 | 32.3 | GO:0015884 | folic acid transport(GO:0015884) |
4.0 | 20.1 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
4.0 | 12.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
4.0 | 28.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
4.0 | 32.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
4.0 | 84.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
4.0 | 32.0 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
4.0 | 16.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
4.0 | 4.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
4.0 | 4.0 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
4.0 | 12.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
4.0 | 7.9 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
4.0 | 7.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
4.0 | 11.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
3.9 | 7.9 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
3.9 | 11.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
3.9 | 43.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
3.9 | 7.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.9 | 47.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
3.9 | 15.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
3.9 | 57.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
3.8 | 42.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) |
3.8 | 7.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
3.8 | 22.9 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
3.8 | 22.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.8 | 11.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.8 | 26.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
3.8 | 15.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.8 | 22.7 | GO:0010044 | response to aluminum ion(GO:0010044) |
3.8 | 68.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.8 | 11.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
3.8 | 15.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.8 | 48.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
3.8 | 15.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
3.7 | 3.7 | GO:0014044 | Schwann cell development(GO:0014044) |
3.7 | 7.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
3.7 | 56.1 | GO:0014002 | astrocyte development(GO:0014002) |
3.7 | 7.5 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
3.7 | 37.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
3.7 | 3.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
3.7 | 14.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.7 | 7.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.7 | 14.8 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
3.7 | 25.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
3.7 | 7.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
3.7 | 7.4 | GO:0070541 | response to platinum ion(GO:0070541) |
3.7 | 3.7 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
3.7 | 33.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
3.7 | 7.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
3.6 | 7.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
3.6 | 3.6 | GO:0007412 | axon target recognition(GO:0007412) |
3.6 | 10.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
3.6 | 18.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
3.6 | 28.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
3.6 | 50.2 | GO:0071625 | vocalization behavior(GO:0071625) |
3.6 | 10.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
3.6 | 7.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
3.6 | 21.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
3.6 | 35.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
3.6 | 25.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.6 | 39.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
3.6 | 10.7 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
3.5 | 7.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
3.5 | 3.5 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
3.5 | 10.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
3.5 | 17.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
3.5 | 21.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
3.5 | 3.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
3.5 | 31.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
3.5 | 7.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
3.5 | 6.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
3.5 | 10.4 | GO:0048749 | compound eye development(GO:0048749) |
3.5 | 20.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
3.5 | 17.3 | GO:0045026 | plasma membrane fusion(GO:0045026) |
3.5 | 34.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
3.4 | 13.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
3.4 | 13.7 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
3.4 | 6.9 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
3.4 | 92.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
3.4 | 47.7 | GO:0042407 | cristae formation(GO:0042407) |
3.4 | 6.8 | GO:0015827 | tryptophan transport(GO:0015827) |
3.4 | 10.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.4 | 6.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.4 | 16.9 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
3.4 | 13.5 | GO:0042853 | L-alanine catabolic process(GO:0042853) |
3.4 | 13.5 | GO:1902617 | response to fluoride(GO:1902617) |
3.4 | 13.5 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
3.4 | 30.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
3.3 | 26.7 | GO:0051181 | cofactor transport(GO:0051181) |
3.3 | 13.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
3.3 | 10.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
3.3 | 13.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.3 | 3.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
3.3 | 3.3 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
3.3 | 19.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
3.3 | 16.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.3 | 3.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.3 | 6.6 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
3.3 | 3.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) |
3.3 | 62.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
3.3 | 9.9 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
3.3 | 23.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
3.3 | 22.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
3.3 | 9.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
3.3 | 19.5 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
3.2 | 9.7 | GO:0030091 | protein repair(GO:0030091) |
3.2 | 32.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
3.2 | 9.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
3.2 | 9.6 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
3.2 | 6.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
3.2 | 9.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.2 | 12.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
3.2 | 9.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
3.2 | 3.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
3.2 | 34.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.2 | 9.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.1 | 18.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
3.1 | 9.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
3.1 | 18.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
3.1 | 9.3 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
3.1 | 52.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
3.1 | 9.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
3.1 | 6.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
3.1 | 6.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.1 | 18.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
3.1 | 24.7 | GO:0007416 | synapse assembly(GO:0007416) |
3.1 | 12.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
3.1 | 3.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
3.1 | 3.1 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
3.1 | 12.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
3.1 | 70.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
3.1 | 6.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
3.0 | 57.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
3.0 | 36.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
3.0 | 15.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
3.0 | 18.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
3.0 | 48.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
3.0 | 15.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.0 | 21.0 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
3.0 | 21.0 | GO:0006108 | malate metabolic process(GO:0006108) |
3.0 | 9.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
3.0 | 8.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
3.0 | 20.8 | GO:0032328 | alanine transport(GO:0032328) |
3.0 | 20.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
3.0 | 17.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.9 | 5.9 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
2.9 | 8.8 | GO:0051012 | microtubule sliding(GO:0051012) |
2.9 | 11.8 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
2.9 | 8.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
2.9 | 11.7 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
2.9 | 17.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
2.9 | 5.8 | GO:1990792 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
2.9 | 11.7 | GO:0021794 | thalamus development(GO:0021794) |
2.9 | 23.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
2.9 | 14.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.9 | 11.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.9 | 14.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.9 | 2.9 | GO:0086009 | membrane repolarization(GO:0086009) |
2.9 | 17.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
2.9 | 11.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.9 | 22.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
2.9 | 14.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
2.9 | 31.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
2.9 | 8.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
2.8 | 8.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.8 | 11.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
2.8 | 8.5 | GO:0009597 | detection of virus(GO:0009597) |
2.8 | 14.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
2.8 | 14.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.8 | 25.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
2.8 | 61.9 | GO:0097503 | sialylation(GO:0097503) |
2.8 | 45.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
2.8 | 14.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.8 | 30.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
2.8 | 19.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.8 | 5.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
2.8 | 8.3 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
2.8 | 8.3 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
2.8 | 13.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.8 | 8.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.8 | 8.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.7 | 16.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
2.7 | 2.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.7 | 13.7 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
2.7 | 5.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) response to chlorate(GO:0010157) |
2.7 | 21.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.7 | 24.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
2.7 | 35.2 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
2.7 | 8.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
2.7 | 8.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.7 | 5.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.7 | 8.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.7 | 8.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
2.7 | 8.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.7 | 13.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.7 | 18.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.7 | 16.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
2.7 | 34.8 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
2.7 | 26.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
2.7 | 37.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
2.7 | 10.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.7 | 26.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
2.7 | 8.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
2.7 | 10.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.6 | 7.9 | GO:0002084 | protein depalmitoylation(GO:0002084) |
2.6 | 15.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.6 | 2.6 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
2.6 | 5.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
2.6 | 5.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.6 | 7.8 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
2.6 | 2.6 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
2.6 | 7.8 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
2.6 | 10.4 | GO:0032919 | spermine acetylation(GO:0032919) |
2.6 | 5.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
2.6 | 2.6 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.6 | 7.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.6 | 7.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.6 | 7.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.6 | 10.2 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
2.5 | 12.7 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.5 | 15.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.5 | 10.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.5 | 5.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
2.5 | 10.1 | GO:0033622 | integrin activation(GO:0033622) |
2.5 | 17.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.5 | 7.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
2.5 | 25.0 | GO:0016926 | protein desumoylation(GO:0016926) |
2.5 | 22.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
2.5 | 7.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
2.5 | 14.8 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.4 | 9.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
2.4 | 4.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.4 | 7.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
2.4 | 36.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
2.4 | 7.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
2.4 | 7.3 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
2.4 | 17.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
2.4 | 7.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.4 | 7.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
2.4 | 7.2 | GO:0021564 | vagus nerve development(GO:0021564) |
2.4 | 93.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
2.4 | 16.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
2.4 | 9.6 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
2.4 | 4.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
2.4 | 26.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.4 | 14.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.4 | 4.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
2.4 | 4.7 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
2.4 | 4.7 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
2.4 | 9.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
2.4 | 7.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
2.4 | 4.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
2.4 | 4.7 | GO:0035973 | aggrephagy(GO:0035973) |
2.4 | 11.8 | GO:0046710 | GDP metabolic process(GO:0046710) |
2.3 | 9.4 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
2.3 | 11.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
2.3 | 7.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
2.3 | 4.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.3 | 9.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.3 | 76.8 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
2.3 | 16.3 | GO:0006465 | signal peptide processing(GO:0006465) |
2.3 | 11.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.3 | 6.9 | GO:0010265 | SCF complex assembly(GO:0010265) |
2.3 | 62.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.3 | 9.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
2.3 | 6.9 | GO:0009758 | carbohydrate utilization(GO:0009758) |
2.3 | 57.3 | GO:0019835 | cytolysis(GO:0019835) |
2.3 | 9.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
2.3 | 6.9 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
2.3 | 64.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
2.3 | 4.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.3 | 4.6 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
2.3 | 4.6 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
2.3 | 6.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
2.3 | 6.8 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
2.3 | 13.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.3 | 13.5 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
2.2 | 4.5 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
2.2 | 9.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
2.2 | 15.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
2.2 | 4.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
2.2 | 24.4 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
2.2 | 75.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
2.2 | 6.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.2 | 17.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
2.2 | 8.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
2.2 | 8.7 | GO:0018158 | protein oxidation(GO:0018158) |
2.2 | 2.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.2 | 4.4 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
2.2 | 8.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
2.2 | 4.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
2.2 | 30.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
2.2 | 4.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.2 | 10.8 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
2.1 | 4.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
2.1 | 4.3 | GO:0006710 | androgen catabolic process(GO:0006710) |
2.1 | 12.8 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
2.1 | 10.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.1 | 95.8 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
2.1 | 6.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.1 | 17.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
2.1 | 27.6 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
2.1 | 12.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
2.1 | 4.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
2.1 | 8.4 | GO:0001757 | somite specification(GO:0001757) collateral sprouting in absence of injury(GO:0048669) |
2.1 | 6.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.1 | 56.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
2.1 | 6.3 | GO:0019086 | late viral transcription(GO:0019086) |
2.1 | 10.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.1 | 12.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.1 | 12.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
2.1 | 20.6 | GO:0002076 | osteoblast development(GO:0002076) |
2.1 | 39.0 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
2.0 | 2.0 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
2.0 | 2.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.0 | 4.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.0 | 16.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
2.0 | 4.1 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
2.0 | 4.1 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
2.0 | 4.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.0 | 4.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
2.0 | 8.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
2.0 | 88.3 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
2.0 | 22.1 | GO:0046697 | decidualization(GO:0046697) |
2.0 | 10.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.0 | 6.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
2.0 | 11.9 | GO:0048539 | bone marrow development(GO:0048539) |
2.0 | 31.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
2.0 | 15.8 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
2.0 | 27.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
2.0 | 84.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.0 | 5.9 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
2.0 | 15.7 | GO:0048243 | norepinephrine secretion(GO:0048243) |
2.0 | 3.9 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
2.0 | 9.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.0 | 7.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.9 | 42.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.9 | 7.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.9 | 48.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
1.9 | 5.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.9 | 11.6 | GO:2000209 | regulation of anoikis(GO:2000209) positive regulation of anoikis(GO:2000210) |
1.9 | 3.9 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
1.9 | 13.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.9 | 17.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.9 | 7.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.9 | 15.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.9 | 20.5 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
1.9 | 11.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.9 | 7.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
1.9 | 24.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.9 | 11.1 | GO:0060721 | regulation of spongiotrophoblast cell proliferation(GO:0060721) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
1.9 | 16.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.8 | 3.7 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
1.8 | 12.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.8 | 22.0 | GO:0032274 | gonadotropin secretion(GO:0032274) |
1.8 | 5.5 | GO:0061042 | vascular wound healing(GO:0061042) |
1.8 | 23.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
1.8 | 5.5 | GO:0051775 | response to redox state(GO:0051775) |
1.8 | 9.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.8 | 9.1 | GO:0009414 | response to water deprivation(GO:0009414) |
1.8 | 1.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.8 | 41.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
1.8 | 1.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
1.8 | 12.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.8 | 5.4 | GO:0014047 | glutamate secretion(GO:0014047) |
1.8 | 53.8 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
1.8 | 17.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.8 | 7.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.8 | 33.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.8 | 8.9 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.8 | 8.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.8 | 1.8 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.8 | 3.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.8 | 8.8 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
1.7 | 3.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.7 | 19.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
1.7 | 19.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
1.7 | 24.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.7 | 5.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
1.7 | 5.2 | GO:0097298 | regulation of nucleus size(GO:0097298) |
1.7 | 29.4 | GO:0010107 | potassium ion import(GO:0010107) |
1.7 | 6.9 | GO:0060346 | bone trabecula formation(GO:0060346) |
1.7 | 3.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.7 | 36.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.7 | 15.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.7 | 3.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.7 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.7 | 1.7 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
1.7 | 10.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.7 | 74.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
1.7 | 5.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.7 | 11.8 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
1.7 | 5.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
1.7 | 10.1 | GO:0015074 | DNA integration(GO:0015074) |
1.7 | 11.8 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
1.7 | 31.9 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.7 | 5.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.7 | 9.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.6 | 8.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.6 | 4.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.6 | 26.3 | GO:0019236 | response to pheromone(GO:0019236) |
1.6 | 19.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.6 | 9.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.6 | 8.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.6 | 4.9 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
1.6 | 4.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.6 | 8.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.6 | 69.6 | GO:0007219 | Notch signaling pathway(GO:0007219) |
1.6 | 9.7 | GO:0060677 | ureteric bud elongation(GO:0060677) |
1.6 | 6.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.6 | 14.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.6 | 11.3 | GO:0042048 | olfactory behavior(GO:0042048) |
1.6 | 4.8 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
1.6 | 1.6 | GO:0002933 | lipid hydroxylation(GO:0002933) |
1.6 | 4.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.6 | 4.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.6 | 52.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.6 | 12.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.6 | 11.1 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
1.6 | 4.7 | GO:0008038 | neuron recognition(GO:0008038) |
1.6 | 15.7 | GO:0006900 | membrane budding(GO:0006900) |
1.6 | 4.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
1.6 | 1.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.6 | 1.6 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
1.6 | 14.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.5 | 7.7 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
1.5 | 13.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
1.5 | 7.7 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
1.5 | 3.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.5 | 4.6 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
1.5 | 6.1 | GO:0031179 | peptide modification(GO:0031179) |
1.5 | 4.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.5 | 9.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.5 | 4.5 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
1.5 | 50.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
1.5 | 9.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.5 | 4.5 | GO:0099612 | protein localization to axon(GO:0099612) |
1.5 | 3.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
1.5 | 6.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.5 | 14.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.5 | 32.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
1.5 | 6.0 | GO:0002188 | translation reinitiation(GO:0002188) |
1.5 | 14.9 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
1.5 | 5.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.5 | 8.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 8.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
1.5 | 13.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.5 | 2.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.5 | 5.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.5 | 4.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.4 | 7.2 | GO:0060068 | vagina development(GO:0060068) |
1.4 | 58.0 | GO:0018208 | protein peptidyl-prolyl isomerization(GO:0000413) peptidyl-proline modification(GO:0018208) |
1.4 | 1.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.4 | 4.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.4 | 2.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.4 | 4.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.4 | 1.4 | GO:0015811 | L-cystine transport(GO:0015811) |
1.4 | 4.3 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.4 | 10.0 | GO:0007588 | excretion(GO:0007588) |
1.4 | 15.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.4 | 14.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.4 | 2.8 | GO:0030242 | pexophagy(GO:0030242) |
1.4 | 2.8 | GO:0030186 | melatonin metabolic process(GO:0030186) |
1.4 | 9.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
1.4 | 7.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
1.4 | 4.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.4 | 4.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.4 | 11.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
1.4 | 6.9 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
1.4 | 11.0 | GO:0007000 | nucleolus organization(GO:0007000) |
1.4 | 5.5 | GO:0061083 | regulation of protein refolding(GO:0061083) |
1.4 | 13.7 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.4 | 5.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
1.4 | 6.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.3 | 14.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.3 | 1.3 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
1.3 | 14.7 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
1.3 | 10.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.3 | 2.7 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
1.3 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.3 | 2.6 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
1.3 | 14.6 | GO:0007097 | nuclear migration(GO:0007097) |
1.3 | 11.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.3 | 2.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.3 | 10.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.3 | 15.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.3 | 6.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.3 | 3.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.3 | 9.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
1.3 | 3.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
1.3 | 3.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.3 | 9.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.3 | 2.5 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
1.3 | 6.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
1.3 | 11.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.3 | 10.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.3 | 2.5 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
1.3 | 3.8 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
1.2 | 21.2 | GO:0031639 | plasminogen activation(GO:0031639) |
1.2 | 1.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.2 | 5.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
1.2 | 2.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.2 | 6.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.2 | 4.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.2 | 4.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.2 | 2.5 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
1.2 | 2.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.2 | 9.7 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.2 | 20.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.2 | 16.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.2 | 4.8 | GO:0070141 | response to UV-A(GO:0070141) |
1.2 | 4.8 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.2 | 10.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.2 | 9.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
1.2 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
1.2 | 31.8 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
1.2 | 34.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
1.2 | 8.2 | GO:0034389 | lipid particle organization(GO:0034389) |
1.2 | 7.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.2 | 4.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.2 | 6.9 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
1.2 | 4.6 | GO:0006272 | leading strand elongation(GO:0006272) |
1.2 | 3.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.2 | 17.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
1.2 | 8.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.1 | 2.3 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
1.1 | 1.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.1 | 27.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
1.1 | 9.1 | GO:0002347 | response to tumor cell(GO:0002347) |
1.1 | 28.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
1.1 | 14.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
1.1 | 3.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
1.1 | 9.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.1 | 68.0 | GO:0000187 | activation of MAPK activity(GO:0000187) |
1.1 | 7.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.1 | 3.4 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
1.1 | 5.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.1 | 10.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 18.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.1 | 26.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.1 | 36.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.1 | 6.5 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
1.1 | 2.1 | GO:0002741 | regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.1 | 7.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.1 | 16.9 | GO:0031103 | axon regeneration(GO:0031103) |
1.1 | 5.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.1 | 8.4 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.1 | 2.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
1.0 | 3.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.0 | 7.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.0 | 6.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
1.0 | 3.1 | GO:0009751 | response to salicylic acid(GO:0009751) |
1.0 | 35.4 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
1.0 | 20.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
1.0 | 4.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.0 | 3.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.0 | 12.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.0 | 3.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.0 | 49.7 | GO:0007612 | learning(GO:0007612) |
1.0 | 9.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.0 | 2.0 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.0 | 24.0 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
1.0 | 86.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 6.0 | GO:0019674 | NAD metabolic process(GO:0019674) |
1.0 | 11.0 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
1.0 | 5.0 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
1.0 | 5.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 2.9 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
1.0 | 16.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
1.0 | 4.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.0 | 4.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.0 | 6.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.0 | 4.8 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
1.0 | 1.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
1.0 | 2.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.0 | 2.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.0 | 5.8 | GO:0019395 | fatty acid oxidation(GO:0019395) |
1.0 | 1.0 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.0 | 21.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
1.0 | 2.9 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.9 | 2.8 | GO:0006983 | ER overload response(GO:0006983) |
0.9 | 5.7 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.9 | 5.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.9 | 13.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.9 | 8.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.9 | 1.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.9 | 9.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.9 | 13.8 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.9 | 4.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.9 | 0.9 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.9 | 1.8 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.9 | 19.8 | GO:0003014 | renal system process(GO:0003014) |
0.9 | 13.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.9 | 6.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.9 | 18.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.9 | 2.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.9 | 0.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.9 | 0.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.9 | 6.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.9 | 6.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.9 | 24.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.9 | 7.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.9 | 3.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.9 | 7.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.9 | 0.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.9 | 1.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.9 | 4.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.9 | 2.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 3.4 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.9 | 1.7 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.9 | 52.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.8 | 10.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.8 | 1.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.8 | 4.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.8 | 1.7 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.8 | 6.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.8 | 0.8 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.8 | 1.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 22.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.8 | 1.7 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.8 | 11.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.8 | 2.5 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.8 | 16.6 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.8 | 9.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.8 | 3.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.8 | 2.4 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 1.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.8 | 2.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.8 | 8.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.8 | 6.5 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.8 | 10.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.8 | 2.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.8 | 18.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.8 | 3.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.8 | 5.5 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.8 | 1.6 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.8 | 2.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.8 | 6.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.8 | 7.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 1.6 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
0.8 | 13.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.8 | 19.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.8 | 1.5 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.7 | 1.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 16.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.7 | 5.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 17.8 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.7 | 5.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.7 | 2.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.7 | 1.5 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.7 | 2.2 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.7 | 3.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 5.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 7.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.7 | 1.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.7 | 2.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 2.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.7 | 0.7 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.7 | 4.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.7 | 2.7 | GO:0061709 | reticulophagy(GO:0061709) |
0.7 | 3.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 4.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.7 | 2.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 4.7 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.7 | 2.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.7 | 2.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 3.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.6 | 2.6 | GO:0051414 | response to cortisol(GO:0051414) |
0.6 | 2.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.6 | 0.6 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.6 | 3.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.6 | 15.3 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.6 | 1.3 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.6 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 5.7 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.6 | 5.7 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.6 | 2.5 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.6 | 13.7 | GO:0021762 | substantia nigra development(GO:0021762) |
0.6 | 3.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.6 | 3.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 4.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 47.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.6 | 4.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.6 | 6.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.6 | 2.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.6 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 5.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.6 | 1.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 0.6 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.6 | 3.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 2.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 2.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 3.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 2.2 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
0.5 | 1.6 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.5 | 2.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 28.4 | GO:0006906 | vesicle fusion(GO:0006906) |
0.5 | 7.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.5 | 2.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 16.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.5 | 2.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.5 | 2.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 3.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.5 | 1.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.5 | 3.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 2.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 3.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.5 | 1.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 2.4 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.5 | 1.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.5 | 2.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.5 | 1.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.5 | 9.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.5 | 2.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.5 | 3.6 | GO:0043278 | response to morphine(GO:0043278) |
0.4 | 3.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.4 | 0.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.4 | 3.0 | GO:0006068 | ethanol catabolic process(GO:0006068) primary alcohol catabolic process(GO:0034310) |
0.4 | 2.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 1.7 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.4 | 4.6 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.4 | 4.2 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 28.0 | GO:0006457 | protein folding(GO:0006457) |
0.4 | 5.8 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.4 | 5.0 | GO:0009268 | response to pH(GO:0009268) |
0.4 | 1.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 3.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.4 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 1.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 0.4 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.4 | 1.1 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) |
0.4 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 3.7 | GO:0006497 | protein lipidation(GO:0006497) |
0.4 | 1.4 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.3 | 2.1 | GO:0046456 | leukotriene biosynthetic process(GO:0019370) icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.3 | 3.4 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.3 | 8.9 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.3 | 1.0 | GO:0009838 | abscission(GO:0009838) |
0.3 | 4.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.3 | 1.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 1.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 19.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.3 | 11.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.2 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 2.5 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.3 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 0.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 4.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 3.2 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 1.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 2.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 1.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 1.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 8.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 4.5 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.2 | 1.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 8.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 1.4 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 1.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 1.5 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 0.9 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 2.1 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
0.2 | 4.3 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.2 | 1.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.2 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.7 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.2 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.2 | 0.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 5.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 3.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.2 | 0.5 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 2.7 | GO:0031572 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 2.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:1900377 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 4.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.8 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.2 | 63.5 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
21.1 | 63.3 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) calcium ion-transporting ATPase complex(GO:0090534) |
19.8 | 59.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
17.7 | 53.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
17.6 | 35.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
17.3 | 51.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
15.0 | 104.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
14.2 | 85.3 | GO:0033269 | internode region of axon(GO:0033269) |
14.0 | 139.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
13.9 | 41.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
13.9 | 41.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
13.7 | 13.7 | GO:0060187 | cell pole(GO:0060187) |
13.1 | 65.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
13.1 | 52.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
13.0 | 52.0 | GO:0044301 | climbing fiber(GO:0044301) |
13.0 | 38.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
12.3 | 49.3 | GO:0097513 | myosin II filament(GO:0097513) |
11.8 | 35.5 | GO:0098830 | presynaptic endosome(GO:0098830) |
11.8 | 59.1 | GO:0035976 | AP1 complex(GO:0035976) |
11.5 | 23.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
11.3 | 56.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
11.3 | 33.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
11.1 | 33.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
10.8 | 32.4 | GO:0045242 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
10.5 | 52.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
10.3 | 165.5 | GO:0031045 | dense core granule(GO:0031045) |
9.9 | 29.6 | GO:0097444 | spine apparatus(GO:0097444) |
9.7 | 126.4 | GO:0043083 | synaptic cleft(GO:0043083) |
9.2 | 110.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
9.1 | 45.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
8.9 | 17.8 | GO:0042583 | chromaffin granule(GO:0042583) |
8.8 | 87.9 | GO:0005883 | neurofilament(GO:0005883) |
8.8 | 26.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
8.8 | 26.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
8.6 | 43.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
8.6 | 34.3 | GO:0044308 | axonal spine(GO:0044308) |
8.4 | 50.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
8.4 | 8.4 | GO:0070820 | tertiary granule(GO:0070820) |
8.4 | 50.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
8.3 | 8.3 | GO:1902710 | GABA receptor complex(GO:1902710) |
8.3 | 24.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
8.3 | 33.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
8.2 | 16.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
8.1 | 16.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
7.9 | 47.4 | GO:0097470 | ribbon synapse(GO:0097470) |
7.8 | 38.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
7.7 | 115.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
7.5 | 89.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
7.3 | 29.4 | GO:0045298 | tubulin complex(GO:0045298) |
7.3 | 21.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
7.2 | 14.3 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
7.1 | 42.9 | GO:1990246 | uniplex complex(GO:1990246) |
7.0 | 49.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
6.9 | 315.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
6.5 | 19.6 | GO:0045203 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
6.5 | 52.2 | GO:0005915 | zonula adherens(GO:0005915) |
6.5 | 149.8 | GO:0032590 | dendrite membrane(GO:0032590) |
6.5 | 91.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
6.4 | 19.3 | GO:0005592 | collagen type XI trimer(GO:0005592) |
6.4 | 76.9 | GO:0016600 | flotillin complex(GO:0016600) |
6.4 | 44.8 | GO:0032584 | growth cone membrane(GO:0032584) |
6.4 | 31.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
6.4 | 12.7 | GO:0033270 | paranode region of axon(GO:0033270) |
6.3 | 19.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
6.2 | 12.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
6.1 | 24.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
6.0 | 29.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
5.9 | 23.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
5.8 | 17.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
5.8 | 34.7 | GO:0005955 | calcineurin complex(GO:0005955) |
5.7 | 62.5 | GO:0071437 | invadopodium(GO:0071437) |
5.6 | 33.7 | GO:0044327 | dendritic spine head(GO:0044327) |
5.4 | 21.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
5.3 | 15.8 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
5.2 | 67.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
5.1 | 35.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
5.1 | 20.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
5.1 | 40.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
5.1 | 15.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
5.0 | 135.7 | GO:0097440 | apical dendrite(GO:0097440) |
5.0 | 60.2 | GO:0005796 | Golgi lumen(GO:0005796) |
5.0 | 15.1 | GO:0070821 | azurophil granule membrane(GO:0035577) tertiary granule membrane(GO:0070821) |
5.0 | 14.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
5.0 | 138.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
4.9 | 19.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
4.9 | 103.9 | GO:0043194 | axon initial segment(GO:0043194) |
4.9 | 14.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
4.8 | 38.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
4.8 | 57.1 | GO:0031143 | pseudopodium(GO:0031143) |
4.7 | 118.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
4.7 | 28.0 | GO:0030478 | actin cap(GO:0030478) |
4.6 | 32.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
4.6 | 41.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
4.5 | 40.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
4.5 | 8.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
4.4 | 444.6 | GO:0043195 | terminal bouton(GO:0043195) |
4.4 | 22.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
4.4 | 22.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
4.4 | 17.7 | GO:0044393 | microspike(GO:0044393) |
4.4 | 180.1 | GO:0043034 | costamere(GO:0043034) |
4.3 | 17.3 | GO:0035363 | histone locus body(GO:0035363) |
4.3 | 29.9 | GO:0061617 | MICOS complex(GO:0061617) |
4.3 | 25.6 | GO:0097443 | sorting endosome(GO:0097443) |
4.3 | 4.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.2 | 12.6 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) GABA-ergic synapse(GO:0098982) |
4.2 | 70.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
4.1 | 66.2 | GO:0043196 | varicosity(GO:0043196) |
4.1 | 12.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
4.1 | 12.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
4.1 | 12.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
4.1 | 12.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
4.0 | 32.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
4.0 | 168.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
4.0 | 124.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
4.0 | 15.9 | GO:0045273 | respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) |
4.0 | 102.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
3.9 | 7.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
3.9 | 11.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.8 | 740.7 | GO:0043209 | myelin sheath(GO:0043209) |
3.8 | 34.3 | GO:0097449 | astrocyte projection(GO:0097449) |
3.7 | 11.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.7 | 250.6 | GO:0043679 | axon terminus(GO:0043679) |
3.7 | 97.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
3.7 | 52.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.7 | 36.9 | GO:0042587 | glycogen granule(GO:0042587) |
3.6 | 21.9 | GO:1990393 | 3M complex(GO:1990393) |
3.6 | 86.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
3.6 | 39.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
3.6 | 54.1 | GO:0016460 | myosin II complex(GO:0016460) |
3.6 | 10.8 | GO:0071942 | XPC complex(GO:0071942) |
3.5 | 94.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
3.5 | 58.8 | GO:0042599 | lamellar body(GO:0042599) |
3.4 | 17.1 | GO:1990696 | USH2 complex(GO:1990696) |
3.4 | 622.3 | GO:0097060 | synaptic membrane(GO:0097060) |
3.4 | 34.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
3.4 | 23.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
3.4 | 64.0 | GO:0034706 | sodium channel complex(GO:0034706) |
3.4 | 114.5 | GO:0030315 | T-tubule(GO:0030315) |
3.4 | 53.8 | GO:0045180 | basal cortex(GO:0045180) |
3.3 | 13.4 | GO:0005827 | polar microtubule(GO:0005827) |
3.3 | 3.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
3.3 | 16.7 | GO:0048179 | activin receptor complex(GO:0048179) |
3.2 | 9.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
3.1 | 18.7 | GO:0098871 | postsynaptic actin cytoskeleton(GO:0098871) postsynaptic cytoskeleton(GO:0099571) |
3.1 | 15.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
3.1 | 36.7 | GO:0030008 | TRAPP complex(GO:0030008) |
3.0 | 17.9 | GO:0032059 | bleb(GO:0032059) |
3.0 | 38.4 | GO:0044754 | autolysosome(GO:0044754) |
2.9 | 28.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.9 | 17.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
2.9 | 14.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
2.8 | 22.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.8 | 8.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.7 | 8.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
2.7 | 8.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.7 | 13.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.7 | 24.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.7 | 8.1 | GO:0008091 | spectrin(GO:0008091) |
2.7 | 13.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.7 | 21.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.7 | 21.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.7 | 13.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
2.7 | 29.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
2.6 | 18.5 | GO:0005869 | dynactin complex(GO:0005869) |
2.6 | 21.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.6 | 5.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
2.6 | 112.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
2.6 | 23.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.5 | 28.0 | GO:0001891 | phagocytic cup(GO:0001891) |
2.5 | 32.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
2.5 | 17.6 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
2.5 | 7.5 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
2.5 | 79.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
2.5 | 14.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.5 | 46.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
2.5 | 22.1 | GO:0005861 | troponin complex(GO:0005861) |
2.5 | 7.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
2.4 | 4.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
2.4 | 7.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.4 | 70.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
2.4 | 145.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.4 | 19.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.3 | 11.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
2.3 | 4.6 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
2.3 | 6.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.3 | 11.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.2 | 211.4 | GO:0005604 | basement membrane(GO:0005604) |
2.2 | 145.4 | GO:0005811 | lipid particle(GO:0005811) |
2.2 | 11.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
2.2 | 11.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
2.2 | 131.8 | GO:0031902 | late endosome membrane(GO:0031902) |
2.2 | 28.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.1 | 12.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.1 | 6.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.1 | 22.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
2.1 | 14.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
2.1 | 12.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.0 | 53.3 | GO:0034707 | chloride channel complex(GO:0034707) |
2.0 | 8.2 | GO:0097196 | Shu complex(GO:0097196) |
2.0 | 22.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
2.0 | 12.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.0 | 8.0 | GO:0070552 | BRISC complex(GO:0070552) |
2.0 | 13.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.9 | 7.8 | GO:0070545 | PeBoW complex(GO:0070545) |
1.9 | 24.3 | GO:0060091 | kinocilium(GO:0060091) |
1.9 | 7.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.8 | 9.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
1.8 | 106.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.8 | 7.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.8 | 25.4 | GO:0030057 | desmosome(GO:0030057) |
1.8 | 63.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.8 | 67.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
1.8 | 1.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.8 | 101.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.8 | 21.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.8 | 5.3 | GO:0031527 | filopodium membrane(GO:0031527) |
1.8 | 17.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.8 | 144.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.8 | 1.8 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
1.7 | 8.7 | GO:0071797 | LUBAC complex(GO:0071797) |
1.7 | 245.8 | GO:0098793 | presynapse(GO:0098793) |
1.7 | 6.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.7 | 6.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
1.7 | 20.1 | GO:0031932 | TORC2 complex(GO:0031932) |
1.7 | 40.0 | GO:0005921 | gap junction(GO:0005921) |
1.7 | 8.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.7 | 3.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.7 | 33.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.6 | 147.8 | GO:0005770 | late endosome(GO:0005770) |
1.6 | 6.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.6 | 67.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.6 | 4.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.6 | 14.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.6 | 85.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
1.6 | 109.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.5 | 441.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.5 | 12.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 52.8 | GO:0042383 | sarcolemma(GO:0042383) |
1.5 | 96.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.4 | 13.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.4 | 4.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
1.4 | 14.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.4 | 67.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.4 | 7.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.4 | 4.2 | GO:0016939 | kinesin II complex(GO:0016939) |
1.4 | 134.7 | GO:0030427 | site of polarized growth(GO:0030427) |
1.4 | 6.9 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.4 | 18.0 | GO:0000124 | SAGA complex(GO:0000124) |
1.4 | 13.8 | GO:0034709 | methylosome(GO:0034709) |
1.4 | 47.9 | GO:0005776 | autophagosome(GO:0005776) |
1.4 | 4.1 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.4 | 2.7 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
1.4 | 16.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.3 | 113.3 | GO:0043235 | receptor complex(GO:0043235) |
1.3 | 18.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.3 | 14.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.3 | 84.8 | GO:0042641 | actomyosin(GO:0042641) |
1.3 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.3 | 10.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.3 | 11.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.3 | 1.3 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
1.3 | 5.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.2 | 4.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.2 | 66.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.2 | 30.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.2 | 9.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
1.2 | 30.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.2 | 639.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.2 | 43.2 | GO:0005581 | collagen trimer(GO:0005581) |
1.2 | 8.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
1.2 | 89.1 | GO:0030027 | lamellipodium(GO:0030027) |
1.2 | 7.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.1 | 4.6 | GO:1990745 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
1.1 | 1.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
1.1 | 2.2 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 84.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.1 | 3.3 | GO:1990879 | CST complex(GO:1990879) |
1.1 | 6.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.1 | 7.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
1.1 | 55.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
1.1 | 6.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 3.2 | GO:0000125 | PCAF complex(GO:0000125) |
1.1 | 6.4 | GO:0016272 | prefoldin complex(GO:0016272) |
1.1 | 5.3 | GO:0097361 | CIA complex(GO:0097361) |
1.0 | 9.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.0 | 4.2 | GO:0032432 | actin filament bundle(GO:0032432) |
1.0 | 97.7 | GO:0030016 | myofibril(GO:0030016) |
1.0 | 63.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.0 | 15.7 | GO:0002102 | podosome(GO:0002102) |
1.0 | 16.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.0 | 3.9 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 9.6 | GO:0034464 | BBSome(GO:0034464) |
1.0 | 1.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.9 | 251.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.9 | 12.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.9 | 14.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 87.0 | GO:0030424 | axon(GO:0030424) |
0.9 | 6.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.9 | 6.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.9 | 2.6 | GO:0033503 | HULC complex(GO:0033503) |
0.9 | 1.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.9 | 570.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.8 | 5.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.8 | 2.5 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
0.8 | 5.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 14.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.8 | 2.4 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.8 | 1.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.8 | 1.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.8 | 6.5 | GO:0031082 | BLOC complex(GO:0031082) |
0.8 | 155.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.8 | 760.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.8 | 8.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 19.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.8 | 16.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.8 | 12.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.7 | 5.8 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 13.7 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.7 | 6.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.7 | 40.1 | GO:0005769 | early endosome(GO:0005769) |
0.7 | 17.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.7 | 10.6 | GO:0030133 | transport vesicle(GO:0030133) |
0.7 | 14.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 57.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.6 | 3.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.6 | 1.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 6.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 73.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.6 | 2.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 9.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 1.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 5.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 16.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 3.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 3.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 6.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 2.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 1.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.5 | 11.1 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 1756.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.4 | 2.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 1.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.7 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 1.0 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.3 | 3.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 9.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.3 | 38.5 | GO:0005773 | vacuole(GO:0005773) |
0.2 | 0.9 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 0.6 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.2 | 44.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 6.3 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.5 | GO:0005713 | chiasma(GO:0005712) recombination nodule(GO:0005713) |
0.2 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.8 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 1.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 95.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 2.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.1 | 84.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
26.0 | 77.9 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
21.2 | 85.0 | GO:0036004 | GAF domain binding(GO:0036004) |
19.1 | 57.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
18.9 | 94.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
18.8 | 93.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
16.0 | 48.1 | GO:0035939 | microsatellite binding(GO:0035939) |
14.8 | 74.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
14.6 | 43.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
13.8 | 55.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
13.7 | 41.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
13.1 | 78.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
12.4 | 99.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
12.4 | 37.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
12.0 | 72.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
12.0 | 60.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
12.0 | 36.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
11.9 | 71.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
11.7 | 35.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
11.5 | 34.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
11.5 | 34.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
11.5 | 45.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
11.4 | 34.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
11.3 | 79.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
10.8 | 32.3 | GO:0004359 | glutaminase activity(GO:0004359) |
10.6 | 95.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
10.4 | 41.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
10.4 | 52.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
10.4 | 83.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
10.3 | 51.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
10.3 | 30.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
10.2 | 71.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
10.1 | 70.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
10.0 | 39.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
9.9 | 39.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
9.6 | 28.9 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
9.4 | 37.4 | GO:0099510 | calcium ion binding involved in regulation of cytosolic calcium ion concentration(GO:0099510) |
9.3 | 111.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
9.3 | 27.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
9.2 | 73.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
9.0 | 45.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
8.9 | 97.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
8.9 | 35.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
8.9 | 26.6 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
8.8 | 123.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
8.8 | 26.4 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
8.8 | 43.8 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
8.7 | 26.2 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
8.7 | 60.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
8.6 | 77.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
8.5 | 42.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
8.5 | 8.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
8.5 | 33.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
8.4 | 50.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
8.3 | 66.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
8.2 | 24.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
8.1 | 81.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
8.1 | 32.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
8.0 | 40.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
7.8 | 39.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
7.8 | 15.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
7.8 | 23.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
7.8 | 31.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
7.6 | 38.2 | GO:0052834 | inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
7.4 | 22.1 | GO:0046911 | metal chelating activity(GO:0046911) |
7.3 | 29.3 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
7.3 | 36.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
7.2 | 28.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
7.1 | 28.6 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
7.1 | 21.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
7.1 | 28.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
7.0 | 28.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
7.0 | 27.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
6.8 | 20.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
6.8 | 6.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
6.8 | 13.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
6.8 | 20.3 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
6.6 | 19.8 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
6.6 | 33.1 | GO:0070052 | collagen V binding(GO:0070052) |
6.6 | 33.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
6.5 | 19.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
6.5 | 13.1 | GO:0015292 | uniporter activity(GO:0015292) |
6.5 | 26.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
6.5 | 19.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
6.5 | 51.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
6.5 | 90.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
6.4 | 12.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
6.4 | 25.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
6.3 | 31.6 | GO:0070404 | NADH binding(GO:0070404) |
6.3 | 138.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
6.2 | 43.6 | GO:0043426 | MRF binding(GO:0043426) |
6.2 | 43.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
6.2 | 24.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
6.2 | 30.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
6.2 | 18.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
6.1 | 24.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
6.1 | 18.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
6.1 | 24.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
6.1 | 24.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
6.1 | 96.9 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
6.0 | 151.1 | GO:0031489 | myosin V binding(GO:0031489) |
6.0 | 24.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
6.0 | 17.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.9 | 47.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
5.9 | 17.7 | GO:2001070 | starch binding(GO:2001070) |
5.9 | 11.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
5.9 | 35.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
5.9 | 17.6 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
5.8 | 17.5 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
5.8 | 17.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.7 | 63.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
5.7 | 46.0 | GO:0071253 | connexin binding(GO:0071253) |
5.7 | 5.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
5.7 | 103.0 | GO:0044548 | S100 protein binding(GO:0044548) |
5.7 | 17.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
5.7 | 28.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
5.7 | 17.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
5.7 | 22.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.7 | 17.0 | GO:0043398 | HLH domain binding(GO:0043398) |
5.7 | 28.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
5.7 | 22.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
5.7 | 17.0 | GO:0017113 | dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
5.6 | 22.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
5.6 | 11.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
5.6 | 61.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
5.6 | 33.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
5.5 | 16.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.5 | 16.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
5.5 | 60.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
5.4 | 65.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
5.4 | 16.2 | GO:0004096 | catalase activity(GO:0004096) |
5.4 | 21.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
5.4 | 21.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
5.4 | 177.5 | GO:0043236 | laminin binding(GO:0043236) |
5.3 | 79.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
5.3 | 15.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
5.3 | 15.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
5.3 | 52.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
5.2 | 20.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
5.2 | 20.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
5.1 | 76.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
5.1 | 30.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
5.1 | 15.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
5.0 | 25.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
5.0 | 69.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
4.9 | 54.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
4.9 | 14.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
4.9 | 14.7 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
4.9 | 19.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
4.9 | 14.6 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
4.8 | 19.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.8 | 33.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
4.8 | 24.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
4.8 | 14.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
4.8 | 14.3 | GO:0032810 | sterol response element binding(GO:0032810) |
4.8 | 90.6 | GO:0015026 | coreceptor activity(GO:0015026) |
4.8 | 157.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
4.7 | 80.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
4.7 | 18.9 | GO:0033149 | FFAT motif binding(GO:0033149) |
4.7 | 23.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
4.7 | 9.4 | GO:0038100 | nodal binding(GO:0038100) |
4.7 | 65.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
4.7 | 18.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
4.7 | 93.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
4.7 | 46.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
4.7 | 32.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
4.6 | 139.1 | GO:0030506 | ankyrin binding(GO:0030506) |
4.6 | 9.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
4.6 | 22.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.6 | 31.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.5 | 31.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
4.5 | 9.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.5 | 18.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
4.5 | 162.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
4.5 | 71.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
4.5 | 268.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
4.4 | 44.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
4.4 | 8.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
4.4 | 48.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
4.4 | 17.5 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
4.3 | 52.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
4.3 | 17.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
4.3 | 60.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
4.3 | 12.9 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
4.3 | 25.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
4.3 | 12.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
4.3 | 12.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
4.3 | 34.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
4.2 | 12.7 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
4.2 | 21.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
4.2 | 12.6 | GO:0019798 | procollagen-proline 3-dioxygenase activity(GO:0019797) procollagen-proline dioxygenase activity(GO:0019798) |
4.2 | 58.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
4.2 | 12.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
4.2 | 16.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
4.1 | 66.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
4.1 | 16.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
4.1 | 36.9 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
4.1 | 28.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.1 | 8.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
4.1 | 16.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.0 | 24.3 | GO:0043495 | protein anchor(GO:0043495) |
4.0 | 32.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
4.0 | 12.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
4.0 | 8.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
4.0 | 40.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
4.0 | 16.0 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
4.0 | 12.0 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
4.0 | 143.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
4.0 | 123.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
4.0 | 23.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
3.9 | 19.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.9 | 47.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
3.9 | 11.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
3.9 | 11.6 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
3.9 | 11.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
3.9 | 7.7 | GO:0048030 | disaccharide binding(GO:0048030) |
3.8 | 15.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.8 | 26.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
3.8 | 19.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
3.8 | 117.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
3.8 | 60.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
3.8 | 15.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
3.8 | 30.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
3.7 | 15.0 | GO:0042806 | fucose binding(GO:0042806) |
3.7 | 14.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
3.7 | 3.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
3.7 | 29.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
3.7 | 70.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
3.7 | 29.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
3.7 | 51.6 | GO:0030955 | potassium ion binding(GO:0030955) |
3.7 | 29.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
3.6 | 10.9 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
3.6 | 14.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.6 | 18.1 | GO:0089720 | caspase binding(GO:0089720) |
3.6 | 25.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
3.6 | 93.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
3.6 | 32.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
3.6 | 7.1 | GO:0043559 | insulin binding(GO:0043559) |
3.6 | 17.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
3.5 | 7.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
3.5 | 10.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
3.5 | 10.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
3.5 | 21.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
3.5 | 20.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
3.5 | 10.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
3.5 | 34.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.4 | 3.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
3.4 | 20.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
3.4 | 10.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
3.4 | 34.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
3.4 | 13.6 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
3.4 | 13.4 | GO:0030984 | kininogen binding(GO:0030984) |
3.4 | 43.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
3.3 | 26.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.3 | 86.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
3.3 | 30.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
3.3 | 30.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
3.3 | 39.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
3.3 | 3.3 | GO:0015142 | tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.3 | 46.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
3.3 | 13.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
3.3 | 75.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
3.3 | 39.2 | GO:0070402 | NADPH binding(GO:0070402) |
3.3 | 9.8 | GO:0048495 | Roundabout binding(GO:0048495) |
3.3 | 16.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
3.3 | 16.3 | GO:0043199 | sulfate binding(GO:0043199) |
3.2 | 3.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
3.2 | 6.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.2 | 29.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
3.2 | 9.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
3.2 | 9.6 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
3.2 | 25.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
3.2 | 15.9 | GO:0051373 | FATZ binding(GO:0051373) |
3.2 | 9.5 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
3.2 | 12.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.2 | 22.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
3.1 | 40.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
3.1 | 12.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
3.1 | 9.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
3.1 | 25.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
3.1 | 65.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
3.1 | 71.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
3.1 | 24.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
3.1 | 12.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
3.1 | 61.7 | GO:0043394 | proteoglycan binding(GO:0043394) |
3.1 | 18.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.1 | 9.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
3.1 | 33.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
3.1 | 12.3 | GO:0031014 | troponin T binding(GO:0031014) |
3.1 | 12.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.0 | 9.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.0 | 9.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
3.0 | 21.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
3.0 | 21.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.0 | 9.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
3.0 | 9.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
3.0 | 11.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.9 | 8.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
2.9 | 17.6 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
2.9 | 29.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
2.9 | 26.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.9 | 5.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.9 | 23.2 | GO:0015232 | heme transporter activity(GO:0015232) |
2.9 | 31.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
2.9 | 14.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.9 | 22.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.9 | 22.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.9 | 8.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.8 | 11.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
2.8 | 71.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
2.8 | 11.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
2.8 | 28.3 | GO:0048156 | tau protein binding(GO:0048156) |
2.8 | 8.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.8 | 14.0 | GO:0004064 | arylesterase activity(GO:0004064) |
2.8 | 16.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.8 | 8.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.8 | 11.2 | GO:0045159 | myosin II binding(GO:0045159) |
2.8 | 19.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.8 | 8.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.8 | 27.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.8 | 22.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.8 | 11.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.7 | 8.2 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
2.7 | 11.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.7 | 41.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
2.7 | 11.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
2.7 | 246.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
2.7 | 16.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.7 | 81.7 | GO:0030507 | spectrin binding(GO:0030507) |
2.7 | 19.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.7 | 271.1 | GO:0044325 | ion channel binding(GO:0044325) |
2.7 | 16.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
2.7 | 8.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.7 | 59.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
2.7 | 21.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
2.7 | 5.4 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
2.7 | 16.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.6 | 13.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.6 | 7.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
2.6 | 88.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
2.6 | 54.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.6 | 18.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
2.6 | 12.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.6 | 95.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
2.6 | 12.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
2.6 | 10.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
2.6 | 15.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
2.5 | 35.4 | GO:0050661 | NADP binding(GO:0050661) |
2.5 | 7.6 | GO:0042731 | PH domain binding(GO:0042731) |
2.5 | 7.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.5 | 25.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
2.5 | 12.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.5 | 9.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.5 | 14.9 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
2.5 | 205.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
2.5 | 56.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.5 | 9.9 | GO:0045545 | syndecan binding(GO:0045545) |
2.5 | 29.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
2.4 | 121.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
2.4 | 43.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
2.4 | 9.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
2.4 | 16.9 | GO:0030957 | Tat protein binding(GO:0030957) |
2.4 | 7.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
2.4 | 4.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.4 | 14.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.4 | 4.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.4 | 14.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
2.4 | 23.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.4 | 21.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.4 | 9.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.4 | 42.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
2.4 | 61.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.4 | 35.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
2.3 | 14.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.3 | 82.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
2.3 | 2.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
2.3 | 11.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
2.3 | 30.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
2.3 | 2.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.3 | 18.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
2.3 | 27.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
2.3 | 4.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.3 | 89.3 | GO:0005518 | collagen binding(GO:0005518) |
2.3 | 139.7 | GO:0005178 | integrin binding(GO:0005178) |
2.3 | 38.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
2.3 | 36.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
2.3 | 11.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
2.3 | 4.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.3 | 11.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.3 | 40.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.3 | 11.3 | GO:0048185 | activin binding(GO:0048185) |
2.3 | 27.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.2 | 4.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.2 | 20.2 | GO:0015266 | protein channel activity(GO:0015266) |
2.2 | 4.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.2 | 6.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
2.2 | 15.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
2.2 | 13.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.2 | 15.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.2 | 8.8 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
2.2 | 13.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.2 | 43.1 | GO:0030552 | cAMP binding(GO:0030552) |
2.1 | 36.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
2.1 | 51.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
2.1 | 34.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
2.1 | 34.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
2.1 | 31.9 | GO:0005537 | mannose binding(GO:0005537) |
2.1 | 6.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.1 | 12.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
2.1 | 10.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
2.0 | 20.4 | GO:0010181 | FMN binding(GO:0010181) |
2.0 | 4.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
2.0 | 22.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.0 | 10.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
2.0 | 22.1 | GO:0030276 | clathrin binding(GO:0030276) |
2.0 | 6.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.0 | 4.0 | GO:0015168 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
2.0 | 19.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.0 | 3.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.0 | 5.9 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
2.0 | 2.0 | GO:0019956 | chemokine binding(GO:0019956) |
1.9 | 31.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.9 | 25.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.9 | 5.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.9 | 11.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.9 | 1.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.9 | 27.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.9 | 32.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.9 | 5.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.9 | 5.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.9 | 22.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.9 | 3.8 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.9 | 7.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.9 | 5.6 | GO:0016015 | morphogen activity(GO:0016015) |
1.9 | 50.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
1.9 | 9.3 | GO:0036033 | mediator complex binding(GO:0036033) |
1.9 | 7.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) |
1.9 | 9.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.9 | 5.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.8 | 22.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.8 | 5.5 | GO:0032564 | dATP binding(GO:0032564) |
1.8 | 5.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
1.8 | 11.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.8 | 3.6 | GO:0015925 | galactosidase activity(GO:0015925) |
1.8 | 20.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
1.8 | 1.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.8 | 39.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.8 | 10.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.8 | 19.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.8 | 25.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
1.8 | 1.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.8 | 8.9 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
1.8 | 10.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.8 | 10.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.8 | 10.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.8 | 17.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.8 | 144.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
1.8 | 3.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.8 | 12.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.8 | 17.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.8 | 49.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.7 | 8.7 | GO:0017166 | vinculin binding(GO:0017166) |
1.7 | 10.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.7 | 103.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.7 | 7.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) dopamine:sodium symporter activity(GO:0005330) |
1.7 | 36.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.7 | 27.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.7 | 13.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.7 | 5.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.7 | 6.9 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
1.7 | 6.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.7 | 53.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
1.7 | 22.4 | GO:0005522 | profilin binding(GO:0005522) |
1.7 | 25.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.7 | 10.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.7 | 5.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
1.7 | 118.8 | GO:0005496 | steroid binding(GO:0005496) |
1.7 | 60.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.7 | 42.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.7 | 10.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.7 | 24.8 | GO:0070403 | NAD+ binding(GO:0070403) |
1.7 | 18.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.6 | 3.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.6 | 8.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.6 | 9.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.6 | 4.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.6 | 17.8 | GO:0051400 | BH domain binding(GO:0051400) |
1.6 | 11.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
1.6 | 4.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.6 | 9.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.6 | 6.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.6 | 12.8 | GO:0031419 | cobalamin binding(GO:0031419) |
1.6 | 8.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.6 | 55.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.6 | 4.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
1.6 | 39.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.6 | 23.7 | GO:0022848 | acetylcholine receptor activity(GO:0015464) acetylcholine-gated cation channel activity(GO:0022848) |
1.6 | 6.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.5 | 12.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.5 | 16.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.5 | 3.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.5 | 3.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.5 | 3.0 | GO:0070905 | serine binding(GO:0070905) |
1.5 | 4.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.5 | 13.5 | GO:0031402 | sodium ion binding(GO:0031402) |
1.5 | 6.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.5 | 8.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.5 | 5.9 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
1.5 | 16.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
1.5 | 2.9 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
1.5 | 5.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.4 | 5.8 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
1.4 | 7.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
1.4 | 2.9 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.4 | 19.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.4 | 18.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.4 | 1.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.4 | 20.7 | GO:0031005 | filamin binding(GO:0031005) |
1.4 | 41.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
1.4 | 5.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.4 | 5.5 | GO:0046790 | virion binding(GO:0046790) |
1.4 | 5.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
1.4 | 5.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.3 | 35.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.3 | 15.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.3 | 27.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.3 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.3 | 3.9 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.3 | 25.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.3 | 2.6 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
1.3 | 3.8 | GO:0048038 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) quinone binding(GO:0048038) |
1.3 | 7.7 | GO:0033691 | sialic acid binding(GO:0033691) |
1.3 | 3.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.3 | 7.6 | GO:0017040 | ceramidase activity(GO:0017040) |
1.3 | 26.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.3 | 2.5 | GO:0071791 | chemokine (C-C motif) ligand 5 binding(GO:0071791) |
1.2 | 8.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.2 | 18.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.2 | 2.5 | GO:0051379 | epinephrine binding(GO:0051379) |
1.2 | 4.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.2 | 11.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.2 | 2.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 9.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.2 | 37.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.2 | 3.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.2 | 21.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
1.2 | 1.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
1.2 | 9.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.2 | 5.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.2 | 15.3 | GO:0015643 | toxic substance binding(GO:0015643) |
1.2 | 5.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.2 | 4.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 7.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.2 | 3.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.2 | 2.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.1 | 5.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 2.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.1 | 30.5 | GO:0017022 | myosin binding(GO:0017022) |
1.1 | 3.4 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
1.1 | 6.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.1 | 4.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.1 | 2.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.1 | 28.6 | GO:0005507 | copper ion binding(GO:0005507) |
1.1 | 26.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
1.1 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 8.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.0 | 232.3 | GO:0003924 | GTPase activity(GO:0003924) |
1.0 | 8.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.0 | 5.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.0 | 2.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 424.7 | GO:0005509 | calcium ion binding(GO:0005509) |
1.0 | 2.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.0 | 10.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 6.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.0 | 7.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.0 | 2.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.0 | 1.9 | GO:0035473 | lipase binding(GO:0035473) |
1.0 | 1.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.0 | 35.3 | GO:0005254 | chloride channel activity(GO:0005254) |
1.0 | 37.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.9 | 6.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.9 | 14.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 5.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.9 | 4.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 9.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.9 | 0.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.9 | 2.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.9 | 8.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 10.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.9 | 7.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.9 | 6.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.9 | 32.3 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.9 | 16.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.9 | 2.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.9 | 11.5 | GO:0051287 | NAD binding(GO:0051287) |
0.9 | 4.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 15.8 | GO:0019842 | vitamin binding(GO:0019842) |
0.9 | 16.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.9 | 13.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.9 | 1.7 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.9 | 9.5 | GO:0008061 | chitin binding(GO:0008061) |
0.9 | 2.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.9 | 23.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.9 | 1.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.8 | 14.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.8 | 25.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.8 | 66.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.8 | 2.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.8 | 5.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.8 | 4.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.8 | 5.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.8 | 107.1 | GO:0003779 | actin binding(GO:0003779) |
0.8 | 2.3 | GO:0019959 | interleukin-8 receptor activity(GO:0004918) interleukin-8 binding(GO:0019959) |
0.8 | 4.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 11.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.8 | 6.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 12.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 15.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 14.3 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 27.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.8 | 6.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.7 | 6.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.7 | 3.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.7 | 47.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.7 | 2.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.7 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 3.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 2.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.7 | 3.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 2.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 14.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.7 | 7.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.7 | 117.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.7 | 21.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.7 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 3.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 0.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.7 | 5.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.7 | 2.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.7 | 13.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.7 | 60.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.7 | 3.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 2.7 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.7 | 2.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.7 | 9.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 6.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.6 | 2.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.6 | 13.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 7.0 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.6 | 1.3 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.6 | 2.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.6 | 3.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 4.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.6 | 1.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.6 | 2.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 4.2 | GO:0016594 | glycine binding(GO:0016594) |
0.6 | 2.9 | GO:0031386 | protein tag(GO:0031386) |
0.6 | 29.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.6 | 13.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 1.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 1.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.6 | 3.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 2.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 4.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 4.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.5 | 1.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.5 | 8.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 2.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.5 | 3.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 4.3 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 2.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 6.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 2.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 2.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 2.9 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.5 | 1.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 3.5 | GO:0016247 | channel regulator activity(GO:0016247) |
0.4 | 3.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 4.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 4.3 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.4 | 1.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.4 | 3.4 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.4 | 2.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 2.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 8.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 4.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 5.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 2.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 2.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.4 | 7.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.4 | 3.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 4.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 5.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 34.0 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 2.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 2.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 8.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 4.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 4.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 16.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 8.0 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 19.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 19.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 23.5 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.3 | 1.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 36.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.3 | 1.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 3.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 5.2 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.2 | 1.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 3.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 40.1 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.2 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 2.6 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 3.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 3.7 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.2 | 3.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 1.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 3.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.5 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 6.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.8 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.5 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 36.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.5 | 13.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
13.2 | 145.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
13.2 | 13.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
12.2 | 12.2 | PID IFNG PATHWAY | IFN-gamma pathway |
6.5 | 194.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
6.4 | 82.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
6.0 | 113.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
5.7 | 11.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
5.4 | 27.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
5.2 | 222.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
5.1 | 122.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
4.8 | 161.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
4.6 | 59.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
4.6 | 77.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
4.4 | 30.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
4.3 | 108.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
4.0 | 23.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
3.8 | 30.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
3.7 | 88.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.6 | 126.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
3.6 | 64.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
3.6 | 25.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
3.5 | 56.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
3.5 | 17.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
3.5 | 121.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
3.4 | 109.3 | PID RAS PATHWAY | Regulation of Ras family activation |
3.4 | 44.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
3.3 | 61.9 | PID ARF 3PATHWAY | Arf1 pathway |
3.2 | 67.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
3.2 | 45.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
3.1 | 64.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
3.0 | 30.3 | ST STAT3 PATHWAY | STAT3 Pathway |
3.0 | 21.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
3.0 | 57.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
3.0 | 74.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
3.0 | 145.9 | PID BMP PATHWAY | BMP receptor signaling |
3.0 | 153.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.9 | 11.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.9 | 11.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
2.8 | 135.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
2.8 | 2.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.7 | 48.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
2.6 | 54.5 | PID ENDOTHELIN PATHWAY | Endothelins |
2.6 | 49.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
2.5 | 22.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
2.5 | 12.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
2.4 | 21.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
2.4 | 49.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.3 | 15.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.3 | 22.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
2.2 | 26.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
2.1 | 60.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
2.1 | 51.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
2.1 | 19.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
2.1 | 40.2 | PID REELIN PATHWAY | Reelin signaling pathway |
2.0 | 4.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
2.0 | 293.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
2.0 | 327.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.9 | 73.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.9 | 46.4 | PID SHP2 PATHWAY | SHP2 signaling |
1.8 | 12.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.7 | 11.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.6 | 8.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.6 | 46.9 | PID RHOA PATHWAY | RhoA signaling pathway |
1.6 | 43.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.6 | 360.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.6 | 74.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.6 | 38.8 | NABA COLLAGENS | Genes encoding collagen proteins |
1.5 | 35.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.5 | 61.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.4 | 2.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.3 | 41.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.3 | 12.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.3 | 22.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.2 | 3.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.2 | 16.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.1 | 20.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.1 | 21.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.1 | 22.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.1 | 13.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.1 | 21.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.1 | 10.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.1 | 15.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 16.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.0 | 3.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 4.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 38.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.9 | 11.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 5.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.9 | 9.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.9 | 9.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.9 | 31.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.9 | 7.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.8 | 21.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.8 | 4.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 11.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.8 | 23.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.8 | 1.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.8 | 3.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 28.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.7 | 12.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 9.1 | PID FOXO PATHWAY | FoxO family signaling |
0.6 | 4.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 8.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 20.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 7.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 25.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.5 | 4.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 49.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 21.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 4.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 2.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 9.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 3.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 2.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 16.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 3.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 46.4 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.2 | 4.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 4.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.5 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.1 | 36.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
13.9 | 208.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
12.5 | 149.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
12.0 | 24.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
9.1 | 81.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
9.0 | 153.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
8.8 | 131.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
8.5 | 102.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
7.9 | 63.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
7.7 | 85.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
7.7 | 7.7 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
7.6 | 205.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
7.4 | 111.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
7.0 | 118.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
6.9 | 117.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
6.7 | 107.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
6.7 | 94.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
6.6 | 39.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
6.5 | 248.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
6.1 | 79.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
5.8 | 104.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
5.7 | 245.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
5.6 | 107.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
5.5 | 88.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
5.4 | 64.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
5.2 | 98.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
5.1 | 30.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
4.8 | 62.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
4.8 | 14.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
4.6 | 83.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
4.5 | 112.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
4.5 | 135.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
4.5 | 125.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
4.5 | 174.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
4.3 | 72.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
4.2 | 46.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
4.0 | 56.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
4.0 | 107.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.8 | 50.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.8 | 42.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.8 | 186.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
3.8 | 113.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.7 | 7.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
3.7 | 156.7 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
3.7 | 55.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.7 | 7.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
3.7 | 106.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
3.7 | 95.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
3.6 | 21.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
3.6 | 46.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
3.5 | 31.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
3.5 | 45.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
3.4 | 54.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.3 | 46.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
3.3 | 56.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
3.2 | 25.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
3.1 | 78.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
3.0 | 137.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.0 | 51.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
3.0 | 42.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.0 | 6.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
3.0 | 47.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.9 | 35.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
2.9 | 40.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.9 | 31.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.9 | 46.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.9 | 17.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.9 | 28.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
2.8 | 58.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
2.8 | 44.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.8 | 49.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
2.7 | 112.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.7 | 35.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
2.7 | 2.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.6 | 18.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.6 | 44.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.6 | 51.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.6 | 7.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
2.5 | 12.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
2.5 | 22.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.5 | 17.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.3 | 37.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
2.3 | 16.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
2.3 | 46.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
2.3 | 47.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
2.3 | 90.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
2.3 | 146.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.2 | 20.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
2.2 | 20.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
2.2 | 52.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
2.2 | 17.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
2.2 | 2.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.2 | 102.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.1 | 42.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.1 | 14.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
2.0 | 98.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
2.0 | 56.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.9 | 5.8 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.9 | 56.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.9 | 32.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.9 | 43.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.9 | 56.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.9 | 3.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.8 | 31.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.8 | 111.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.8 | 25.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.8 | 8.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
1.8 | 10.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.7 | 29.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.7 | 29.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.7 | 3.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.7 | 55.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
1.7 | 8.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.5 | 10.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.5 | 108.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.5 | 21.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.5 | 7.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.5 | 14.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.5 | 8.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.4 | 23.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.4 | 26.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.4 | 17.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.4 | 8.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.4 | 16.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.4 | 17.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.3 | 50.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.3 | 29.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 15.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.3 | 22.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
1.3 | 49.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.3 | 22.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.3 | 16.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.3 | 26.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.3 | 20.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.3 | 12.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.3 | 86.4 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
1.2 | 22.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.2 | 18.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.2 | 9.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.2 | 19.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.2 | 7.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.2 | 18.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.2 | 104.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.1 | 7.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.1 | 40.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.1 | 5.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.1 | 2.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.0 | 132.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.0 | 25.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
1.0 | 10.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.9 | 9.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 11.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.9 | 12.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.9 | 17.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 3.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.9 | 9.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.9 | 7.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.9 | 89.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.9 | 36.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.9 | 27.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.8 | 3.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.8 | 45.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.7 | 11.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 5.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.7 | 19.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.7 | 11.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 29.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.7 | 66.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 14.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 6.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 3.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 4.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.5 | 1.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 4.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 2.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 8.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 27.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.5 | 11.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.5 | 2.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 14.8 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.4 | 13.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 6.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 4.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 7.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 8.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 8.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 36.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 4.1 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.3 | 12.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 6.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 2.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.2 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 2.7 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 2.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 5.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |